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ABSTRACT
The present set of studies assessed the relation between neural, psychological, and
cognitive mechanisms that have been shown to influence the experience of chronic pain.
Specifically, Studies One and Two advanced our understanding of chronic pain by illustrating its
unique relationship with anxious arousal and frontal neural activity on inhibitory control
difficulties. Study Three focuses on targeting how anxious arousal is distinctly associated with
neural correlates of inhibitory control in order to provide a framework that can be applied to
individuals experiencing chronic pain. Together, these studies aim to inform the development of
evidenced-based interventions that target anxious arousal in order to enhance the effectiveness of
chronic pain management. Overall, the findings from this set of studies highlighted the crosssectional relation between EF, psychological symptoms, and neural mechanisms and specifically
distinguished the importance of anxious arousal, inhibitory control, and neural mechanisms
measured with EEG (i.e., frontal alpha and beta) and ERP (N200, N450, Conflict SP)
methodologies.
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CHAPTER ONE
INTRODUCTION
Chronic pain can be classified as recurrent or persistent physical discomfort and is one of
the most costly, debilitating, and common conditions affecting individuals of all ages. Chronic
pain is prevalent in childhood and adolescence with studies showing chronic pain pervasiveness
ranging from 8% - 40% (King et al., 2011). Many children and adolescents with chronic pain
may continue to suffer from pain well into adulthood (Fearon & Hotopf, 2001; Walker et al.,
2010). Chronic pain affects over 20% of people worldwide and it accounts for 15-20% of all
physician visits (Treede et al., 2015). Multiple studies have shown that chronic pain has a
detrimental effect on physical and psychological health, daily activity, employment, and
economic well-being (Smith et al., 2001). Chronic pain conditions are also associated with a
costly societal burden. In the UK, chronic back pain alone accounts for an estimated 45 million
days of work lost per year (Smith et al., 2001). In the US, chronic pain is responsible for over
600 million dollars in annual healthcare costs and lost productivity (Zale & Ditre, 2015).
Although definitions vary, chronic pain is typically defined as pain lasting more than
three months (Merskey & Bogduk, 1994). It is characterized as pain that persists past indicated
healing time and lacks the acute warning function of physiological nociception (i.e., the
physiological process by which body tissues are protected from damage; Treede et al., 2015).
Chronic pain is a significant health concern that impacts quality of life and several domains
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of daily functioning (e.g., missed school days, cognitive functions, psychological health). Studies
have found that chronic pain severely affects sleep duration and quality, the ability to exercise,
walk, do household chores, attend social activities, and maintain an independent lifestyle
(Breivik et al., 2006). Further, individuals with chronic pain reported that their pain impacted
their employment status, leading some individuals to switch from full- to part-time work, or
change jobs entirely due to their inability to meet job demands (Breivik et al., 2006). Low
household income and unemployment are significant socioeconomic sequelae of chronic pain
(Johannes et al., 2010). Chronic pain is a public health issue that poses substantial burdens on
afflicted individuals.
Despite the significant societal costs, many individuals with chronic pain are not
receiving adequate treatment for a variety of reasons, including adverse medication side effects,
discussions with medical providers indicating nothing more can be done to alleviate pain, or
deciding to live with their pain without additional interventions due to the burden of pursuing
other options (Breivik et al., 2006). Medical treatment for the majority of chronic pain patients is
often in the form of non-steroidal anti-inflammatory drugs (i.e., NSAIDs), or weak opioid
analgesics, that show little short- or long-term relief (Breivik et al., 2006). Current treatments for
chronic pain are minimally effective and need to be improved in order to provide clinically
significant relief (Breivik et al., 2006).
Theoretical Models of Chronic Pain
Biomedical models of chronic pain have been around for thousands of years (Asmundson
et al., 2004), though a grasp on the underlying mechanisms remains elusive. In the early 2000s,
researchers primarily focused on the physiological components of chronic pain (Asmundson et
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al., 2004), but this biological perspective has fallen short in accounting for the vast individual
differences in pain presentation, pain perception, and the propensity to develop chronic pain.
More recently, research has focused on understanding the experience of pain through theoretical
models that integrate biological and psychosocial factors associated with chronic pain. For
example, the fear-avoidance model of chronic pain theorizes that anxiety is the intervening
variable between fear and avoidance behavior, such that when an individual is anxious due to
anticipated pain or injury, the cognitive (i.e., the narrowing of attention to threat cues),
physiological (i.e., autonomic arousal), and motivational (i.e., the desire to prevent anticipated
pain or injury) components of anxiety are evoked (Asmundson et al., 2004). Expectancies and
attentional shifts may promote hypervigilance for evidence of potential pain or injury, painrelated memories, and pain-relevant schemas. These schemas may be activated to filter and
appraise the evidence of pain, and autonomic activation is primed to avoid or protect against the
potential threat (Asmundson et al., 2004). Pain-related fear can be negatively reinforced by
avoidance behaviors (i.e., avoidance of fearful stimuli may reduce fear in the short-term, but
strengthens fear response in the long-term; Zale & Ditre, 2015). By accounting for the
components of anxiety (i.e., the cognitive, physiological, and motivational aspects), this model
provides an explanation for levels of pain intensity that may not be congruous with actual injury.
It further provides explanation for pain that occurs in the absence of identifiable injury or
pathology. The fear-avoidance model posits that pain-related fear activates psychological
mechanisms that lead to the avoidance of movement and activity (Zale & Ditre, 2015). Although
this behavior may be adaptive in the context of acute pain, long-term avoidance of physical

4
activity may impair functioning, reduce participation in occupational and recreational activities,
increase negative mood, and contrive to greater levels of disability (Zale & Ditre, 2015).
While this model has contributed to advancing theories regarding how anxiety
contributes to the maintenance of chronic pain through possible pain or injury anticipation
contexts, it fails to disentangle the neuropsychological mechanisms by which anxiety perpetuates
chronic pain. Further, studies examining the role that other psychological symptoms, such as
depression, play in chronic pain have shown variable results (Romano & Turner, 1985). By
understanding what factors sustain an individual’s experience of living in a body that chronically
interprets exteroceptive and interoceptive stimuli as uncomfortable and noxious, we can aim to
develop more effective treatments for chronic pain. The three studies included in this dissertation
seek to advance our understanding regarding the interrelated nature of the neural, psychological,
and cognitive mechanisms associated with chronic pain in order to ultimately inform the
development of evidenced-based interventions.
The Role of Anxious (Somatic) Arousal and Cognitive Control in Chronic Pain
Although multiple psychological symptoms are associated with chronic pain, somatic
symptoms are an important focus of chronic pain research due to their high rate of co-occurrence
with chronic pain (Bettendorf et al., 2008; Latthe et al., 2006). Somatic symptoms have
traditionally been defined as physical symptoms of unknown pathology and measured as
individual symptoms or as symptom constellations (Dhossche et al., 2001; Steinhausen, 2006).
However, this term has been highly criticized due to its diagnostic inflation, or the high
probability of misdiagnosing a medical illness, and its inefficacy in capturing the true pain
experience those afflicted are facing, despite unknown pathology (Katz et al., 2015). A more
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encompassing term, somatic arousal, is synonymous with “anxious arousal” and consists of an
enduring pattern of hypervigilance, sympathetic nervous system hyperarousal to mild stressors,
and state fear (Sharp et al., 2015). Anxious arousal has historically been conceptualized within
the psychopathology literature as a distinct dimension or subtype of anxiety per the framework of
the tripartite model of anxiety and depression (Clark & Watson, 1991). The tripartite model,
which aimed to explain the co-occurrence between anxiety and depression syndromes, suggests
that although anxiety and depression share a substantial component of general affective distress
(i.e., negative affect), they can be differentiated on the basis of factors specific to each syndrome
(Clark & Watson, 1991). Clark & Watson (1991) theorized that anhedonia, or a reduced ability
to experience pleasure and/or diminished interest in engaging in pleasurable activities, was
uniquely related to depression, and anxious arousal was hypothesized to be distinct to anxiety.
While some studies have used descriptors such as ‘worry,’ ‘panic,’ or ‘fear’ to characterize
anxious arousal, these terms are theorized to better represent state anxiety in response to an
acutely threatening situation and are distinguished as another subtype of anxiety known as
anxious apprehension (Sharp et al., 2015). Anxious arousal has been differentiated as a traitbased construct referring to the propensity to experience state fear more often and more easily
with a temporally stable pattern of hypervigilance between acute fear responses (Sharp et al.,
2015). The fear-anxiety-avoidance model has suggested explanations for individual differences
in pain perception such that anxiety may be the mediating factor between fear and avoidance
behavior that is often observed in chronic pain. However, the mechanism by which anxiety
perpetuates chronic pain is not yet understood. Additionally, as depression frequently co-occurs
with anxiety (Gorman, 1996), understanding the specific differences and synergistic
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characteristics of co-occurring symptoms is imperative to understanding how psychological
symptoms are associated with chronic pain (Sartorius et al., 1996; Zahn–Waxler et al., 2000).
Applying dimensional approaches to psychological symptoms (i.e., affectivity, anxious arousal,
anxious apprehension) that transcend traditional categorical classification (i.e.,
depression/anxiety; (Blanchard-Fields, 2005; Blanchette & Richards, 2010; Mitchell & Phillips,
2007; Yiend, 2004) may characterize dimensions of psychological function that are associated
with chronic pain more accurately.
Not only are psychological symptoms associated with chronic pain, but those suffering
from chronic pain have also endorsed difficulties with cognitive control, which may impair the
ability to control thoughts, feelings, and emotions (Muraven et al., 1998; Richards & Gross,
2000). Cognitive control, or executive functions (EFs), are interrelated high-level cognitive
domains including inhibition, shifting, and updating, that enable individuals to successfully
navigate day-to-day experiences. EFs are implemented by prefrontal cortex (PFC) and represent
a collection of interrelated domains that enable individuals to modify their thoughts and
behaviors (Solberg et al., 2009). Individuals with chronic pain have reported significantly
impaired overall EF compared to those not in chronic pain (Baker et al., 2016; Berryman et al.,
2014). EF impairments, specifically impairment in inhibitory control function, have also been
experimentally observed in individuals who experience chronic pain (Buhle & Wager, 2010;
Glass et al., 2011). Inhibitory control is defined as the capacity to inhibit or regulate prepotent
responses, or the ability to stop a planned or ongoing thought or action (Williams et al., 1999).
Inhibitory control is required in many activities of daily living in which an individual needs to
tune out stimuli that are irrelevant to a task or process at hand. Beyond cognitive capacities
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needed for the regulation of emotional distress, the demands of chronic pain also include
managing the pain itself through redirecting or shifting attention and inhibiting or suppressing
ruminative thoughts about pain (Solberg et al., 2009). Because similar brain regions, particularly
anterior cingulate cortex (ACC), have been implicated in pain, executive function, and emotional
regulation, difficulties regulating emotional distress may be due to “cognitive overload,”
whereby the added challenges of chronic pain may fatigue or tax self-regulatory strength (Glass
et al., 2011; Shackman et al., 2011; Solberg et al., 2009). Understanding how chronic pain is
associated with psychological symptoms (particularly anxious arousal) and inhibitory control
abilities may aid in finding effective treatments aimed at targeting these synergistic constructs.
The present set of studies assesses the relation between neural, psychological, and
cognitive mechanisms that have been shown to influence the experience of chronic pain. Studies
One and Two advanced our understanding regarding the interrelated nature of these mechanisms.
Study Three focuses on targeting how these mechanisms may relate to each other in order to
provide a framework that can be applied to individuals experiencing chronic pain.
Overview of Study One: Somatic Symptoms Distinctly Influence Visceral Nociception in
Primary Dysmenorrhea
The first study, “Somatic Symptoms Distinctly Influence Visceral Nociceptive
Mechanisms in Primary Dysmenorrhea,” was expanded from my Master’s thesis, which
investigated the psychological and neural correlates associated with increased sensitivity to
experimental pain in a sample of women with dysmenorrhea (i.e., painful menstrual cramps)
compared to women without dysmenorrhea. This study focused on the role of psychological
symptoms and neural mechanisms that impact visceral (i.e., relating to the internal organs of the
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body) pain sensitivity to better elucidate the mechanisms that influence the experience of
noxious stimuli. Women with dysmenorrhea (n = 106) and healthy controls (n = 24) participated
in the study. Psychological symptoms (i.e., somatic symptoms, depression, anxiety) were
assessed with questionnaire measures and visceral pain sensitivity was evaluated via
experimentally induced bladder pain. Resting state PFC activity was studied with
electroencephalography (EEG).
Overall, the findings from this study indicated that dysmenorrhea diagnosis and high
levels of somatic symptoms, or somatic arousal, were predictive of increased pain perception via
an experimental pain task. Depression and anxiety were associated with experimental bladder
pain. Further, resting state brain activity in the alpha and beta oscillatory bands were associated
with experimental pain and anxiety, respectively. Together, these findings provide evidence that
for individuals experiencing chronic pain, somatic (i.e., anxious) arousal and related neural
mechanisms (e.g., frontal alpha and beta activity) are associated with increased pain perception
in the presence of noxious stimuli.
This study shows associations between frontal alpha and beta activity with experimental
bladder pain, and abnormalities in PFC function have also been implicated in somatic symptoms
(Hakala et al., 2002) as well as depression and anxiety disorders (Latthe et al., 2006). Frontal
alpha activity has been associated with anticipatory processes, attentional demands, and
cognitive control (Klimesch et al., 1998; Klimesch, 1999; Michels et al., 2008) which play a key
role in pain perception and modulation (Moont et al., 2010; Quiton & Greenspan, 2007). Frontal
beta power is also linked to chronic pain and it has been localized to cortical networks involved
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in both cognitive control functions and pain response, such as anterior cingulate, prefrontal, and
somatosensory cortices (Stern et al., 2006; Vanneste et al., 2017).
Since chronic pain and somatic symptoms are both associated with abnormalities in
frontocingulate networks, and given the evidence supporting an association between affect and
pain, understanding the multidimensionality of chronic pain-related symptoms is imperative in
developing effective treatment. While Study One elucidated the importance of psychological
symptoms, particularly somatic (i.e., anxious) arousal, and frontal resting-state activity on pain
perception for individuals experiencing chronic pain, it did not account for the role of inhibitory
control, which is implicated in pain perception and modulation per the fear-anxiety-avoidance
model (Asmundson et al., 2004). Study Two was conducted to further understand the relations
between chronic pain and psychological symptoms by studying their effects on inhibitory
control.
Overview of Study Two: Chronic Pain and Inhibitory Control in Emerging Adults: The
Role of Psychological Symptoms
In order to further investigate the relation between psychological symptoms (i.e.,
affectivity, anxious (i.e., somatic) arousal, and anxious apprehension/worry) and inhibitory
control in the context of chronic pain, Study Two was implemented to identify the effects of
chronic pain and the unique and synergistic effects of psychological symptomatology on
inhibitory control. Specifically, to extend the findings from Study One, this study tested the
hypothesis that emerging adults with chronic pain would have a symptom profile primarily
characterized by anxious (i.e., somatic) arousal. Further, I hypothesized that anxious arousal
would distinctly influence the relation between chronic pain and inhibitory control function. This
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study used self-report measures of pain, anxious arousal, anxious apprehension (i.e., worry),
affectivity, and inhibitory control abilities to study a sample of emerging adults (N = 2345, ages
18 - 27). This age range has been identified as a critical developmental window for executive
function optimization, particularly inhibitory control, and those experiencing chronic pain may
be especially vulnerable to inhibitory control deficits (Blyth et al., 2004; McCracken & Turk,
2002; Stinson et al., 2014).
Emerging adults with chronic pain represent a unique population to study inhibitory
control as they face many challenging transitions with respect to developmental tasks (e.g.,
organizational skills, independence from caregivers), social development (e.g., sexuality, peer
relationships), and healthcare systems (i.e., transition from pediatric to adult services). Thus,
emerging adulthood may be a critical window of opportunity to better understand the
relationship between chronic pain and inhibitory control via psychological symptoms
(particularly anxious arousal), in order to optimize and solidify positive health behaviors to
prevent long-term trajectories of severe pain and disability. Psychosocial interventions that
specifically target psychological symptoms affecting inhibitory control may improve function in
young adults with chronic pain, which could lead to more effective treatment of chronic pain
symptoms into adulthood.
Overview of Study Three: Anxious Arousal and Anxious Apprehension are Distinctly
Related to the Temporal Course of Response Inhibition
Building on findings from Study One and Study Two regarding the critical role of
anxious arousal symptoms on increasing experimental pain discomfort and decreasing inhibitory
control function in individuals with chronic pain, Study Three was conducted in an exploratory
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manner to evaluate how anxious arousal and anxious apprehension differentially influence the
implementation of the temporal course of neural activity during response inhibition. Previous
research investigating these anxiety subtypes has been conducted mostly within the context of
experimental tasks involving affective stimuli using functional Magnetic Resonance Imaging
(fMRI), which has poor temporal resolution. Behavioral (i.e., response reaction time and task
accuracy) and the temporal course of neural activity through event-related potentials (ERP)
components (N200, N450, and conflict SP) were analyzed. This study used the Color-Word
Stroop Test (Stroop, 1935), a neuropsychological test that assesses prepotent response inhibition.
This study used a sample of undergraduate students (N = 92) to elucidate the distinct
contributions of anxious arousal and anxious apprehension on inhibitory control. The study used
both categorical and dimensional approaches to examining anxiety symptoms to probe the
relations among distinct dimensions of anxiety along with the behavioral and neural correlates of
response inhibition. Using an experimental psychophysiological measure of cognitive control to
study the temporal course of response inhibition contributed to advancing the understanding of
anxious arousal on inhibitory control. This contributed to the broader goal of informing research
intervention efforts for individuals suffering from chronic pain.

CHAPTER TWO
SOMATIC SYMPTOMS DISTINCTLY INFLUENCE VISCERAL NOCICEPTION IN
PRIMARY DYSMENORRHEA
Chronic pelvic pain conditions are difficult to treat but are often associated with
potentially reversible risk factors such as anxiety, depression, somatic symptoms, and
dysmenorrhea (Dawood, 1985; Westling et al., 2013; Zondervan et al., 2001). Dysmenorrhea
(painful periods) affects between 25-75% of menstruating women. Dysmenorrhea is
characterized by painful menstrual cramps and often occurs in the absence of pelvic pathology in
young women (Dawood, 1985; Harel, 2006; Westling et al., 2013; Zondervan et al., 2001).
Although prostaglandin mediated uterine contractions likely cause cramping pain, recent work
has suggested that neurological changes also occur that could contribute to increased visceral
(internal) organ sensitivity (Dawood, 2006; Hellman et al., 2017; Iacovides et al., 2015; Milsom
et al., 1994; Vincent et al., 2011). Improving our understanding of the neural mechanisms that
contribute to dysmenorrhea and co-occurring visceral pain could lead to the development of
better preventative strategies. Visceral pain refers to pain originating from the internal organs,
most notably the thoracic, abdominal, and pelvic structures (Gebhart, 2000). Visceral pain is
often diffuse and difficult to localize, making it challenging to treat. Among other types of
visceral pain, one of the most debilitating endured by women across the world is dysmenorrhea.

12

13
Susceptibility to pain sensitivity may be a primary risk factor for developing chronic
pelvic pain for women with dysmenorrhea. Women with dysmenorrhea have reported higher
sensitivity to experimental pain, even during phases of the menstrual
cycle when pain is not experienced (Bajaj et al., 2002; Iacovides et al., 2015). Even in the
absence of chronic pelvic pain, studies have shown that women with dysmenorrhea have
increased visceral sensitivity during spontaneous bladder fullness (Tu et al., 2013).
Neurobiological Correlates of Visceral Pain
Activity in brain regions associated with increased risk for chronic visceral pain has not
yet been characterized. However, it has been shown that women with primary dysmenorrhea
have alterations in frontal connectivity (Gu et al., 2010), descending pain modulatory circuitry,
and entorhinal cortex (Vincent et al., 2011). Previous studies have not specifically examined
women while they are simultaneously experiencing menstrual cramps, although studies have
examined what occurs during experimentally evoked visceral pain. Experiments such as
colorectal distension evokes an increase in anterior cingulate cortex (ACC) activity, with
increased ACC activity in participants with chronic visceral pain (Mayer et al., 2005; Silverman
et al., 1997). Conversely, lesioning (or inhibiting) ACC can eliminate perceived aversiveness to
pain (Gu et al., 2010; Qu et al., 2011). ACC is a critical junction box for affective and cognitive
processing, and it has been implemented in affective, social, and physical pain perception
(Eisenberg et al., 2010; Fuchs et al., 2014; Kondo et al., 2004; Mayer et al., 2005; Rotge et al.,
2014; Silverman et al., 1997). Innovatively designed studies using hypnosis have shown that
ACC is primarily involved in the affective processes related to pain response, while
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somatosensory cortex is primarily associated with the bottom-up detection of noxious input
(Rainville et al., 1997).
ACC is part of a network of frontal brain structures involved in top-down attentional
control functions (Silton et al., 2010). Activation of the frontal-limbic network has been
theorized to support effective coping strategies during pain anticipation (Berman et al., 2008).
During the anticipation of a painful stimulus, patients with visceral pain are less likely to engage
frontal mechanisms to down-regulate limbic activity (Berman et al., 2008). Related, frontal
cortical hyperactivity has been observed in patients with chronic pain. Frontal hyperactivity was
shown to modulate cognitive appraisal of pain-relevant emotional signals from the limbic system
(Bernstein et al., 2002). Frontal activity during pain has been linked to affective processing, with
bilateral dorsolateral prefrontal cortices (DLPFC) negatively correlated with intensity perception
and unpleasantness (Lorenz et al., 2003; Lorenz & Casey, 2005). The inter-regional association
between midbrain and medial thalamic activity was significantly reduced during increased left
DLPFC activity (Lorenz & Casey, 2005), which suggests that pain affect may reduce
connectivity within the midbrain-medial thalamic pathway. Right DLPFC was associated with a
weakened relationship with the anterior insula with regard to pain intensity and affect, suggesting
that the DLPFC actively regulates pain perception by modulating cortical pathways (Lorenz et
al., 2003).
However, most visceral pain research has focused on gastrointestinal disorders, largely
overlooking pain mechanisms in women with dysmenorrhea. Heightened pain sensitivity in
women with dysmenorrhea might be associated with disinhibition of thalamo-orbitiofrontalprefrontal networks that contribute to maintain thalamic sensitization (Tu et al., 2009, 2010).
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This could induce compensatory inhibitory mechanisms in somatic sensorimotor regions, as well
as dysfunctional DLPFC mechanisms which could be associated with increased negative affect
(Berkley, 2013; Tu et al., 2010). One of the only other studies on dysmenorrhea and pain (but not
during menses), showed increased limbic activity in women with dysmenorrhea that was linked
to increased duration of dysmenorrhea (Vincent et al., 2011).
Frontal cortical brain activity is also often indexed using electroencephalography (EEG)
methods to study theta (4 -7 Hz), alpha (8 – 13 Hz), and beta (14 – 30 Hz) oscillatory activity.
Beta power has also been linked to chronic pain, such that beta power has been localized to
cortical networks involved in both cognitive control functions and pain response, such as anterior
cingulate, prefrontal, and somatosensory cortices in patients with fibromyalgia (Stern et al.,
2006; Vanneste et al., 2017). Studies on pain have reported that both the beta and alpha
frequencies are correlated with both transient and tonic noxious painful experiences and may
reflect individuals’ tonic pain responsiveness (Vanneste et al., 2017). Gonzalez-Roldan et al.
(2016) found that patients with fibromyalgia had enhanced beta activity during resting state that
was localized to right precentral gyrus, right middle frontal gyrus, superior frontal gyrus,
midcingulate cortex, and right medial frontal gyrus. Further, studies have found a strong
association with pgACC activity in the beta frequency range and pain vigilance and awareness
(Vanneste et al., 2017). Enhanced frontal beta power may be a critical indicator of risk for
chronic pain. Beta activity has been associated with the continuation of a cognitive set that
overrides the effect of potentially unexpected external events (Engel & Fries, 2010). Beta is
theorized to increase during maintenance of a cognitive set, particularly if a change or
interruption is anticipated (Engel & Fries, 2010). Thus, enhanced beta activity is hypothesized to
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be associated with perseveration, or a reduction in cognitive control and flexibility (Engel &
Fries, 2010). Individuals who live with chronic pain may experience poor cognitive control
(Shackman et al., 2011), which could be related to frequent and perseverative rumination about
pain, or repetitively thinking about the causes and consequences of negative pain-related
experiences (Sullivan et al., 2001). Persistent beta activity may result in abnormal persistence of
a cognitive set and inhibit flexible cognitive control (Vanneste et al., 2017).
Reduced alpha power has been repeatedly associated with the administration of noxious
stimuli (Nir et al., 2012) and has also shown to have a strong association between increased
pregenual anterior cingulate cortex (pgACC) activity in the alpha frequency range and pain
modulation (Vanneste et al., 2017). Increased dACC and sgACC in the alpha frequency range
has been shown to be involved in the affective component of pain, which also correlates with
depression (Vanneste et al., 2017). Within the alpha band, two to three sub-bands have been
defined across various studies, each with its own pattern of desynchronization: lower alpha-1 (710 Hz) in considered to reflect anticipatory processes and attentional demands (Klimesch et al.,
1998; Klimesch, 1999; Michels et al., 2008) which have a key role in pain perception and
modulation (Moont et al., 2010; Quiton & Greenspan, 2007). Upper alpha (approximately 10-12
Hz) desynchronization represents task specific requirements (e.g., semantic memory functions,
visuo-motor processes; Nir et al., 2012). Some studies have called for two lower alpha bands that
reflect attentional demands such as alertness and expectancy (i.e., lower alpha-1: approximately
6-8 Hz and lower alpha-2: approximately 8-10 Hz), with lower alpha-1 representing phasic
alertness and lower alpha-2 reflecting expectancy (Klimesch et al., 1998).
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Less is known regarding theta frequency bands in relation to chronic pain, although
increased dorsal ACC (dACC) and subgenual ACC (sgACC) as well as medial prefrontal cortex
(mPFC) and DLPFC activity has been correlated with fatigue in individuals diagnosed with
fibromyalgia and experiencing chronic pain (Vanneste et al., 2017).
Co-occurrence of Psychological Symptoms in Dysmenorrhea
Although multiple psychological symptoms may be associated with visceral pain, its
relationship to somatic symptomatology has been an area of focus (Bettendorf et al., 2008; Latthe
et al., 2006). Somatic symptoms have traditionally been defined as physical symptoms of
unknown pathology and measured as individual symptoms or as symptom constellations
(Dhossche et al., 2001; Steinhausen, 2006). However, this term has been highly criticized due to
its diagnostic inflation, or the high probability of misdiagnosing a medical illness, and its
inefficacy in capturing the true pain experience those afflicted are facing, despite unknown
pathology (Katz et al., 2015). A more encompassing term, somatic arousal, is synonymous with
“anxious arousal” and consists of an enduring pattern of hypervigilance, sympathetic nervous
system hyperarousal to mild stressors, and state fear (Sharp et al., 2015). Anxious arousal has
historically been conceptualized within the psychopathology literature as a distinct dimension or
subtype of anxiety per the framework of the tripartite model of anxiety and depression (Clark &
Watson, 1991). The tripartite model, which aimed to explain the co-occurrence between anxiety
and depression syndromes, suggests that although anxiety and depression share a substantial
component of general affective distress (i.e., negative affect), they can be differentiated on the
basis of factors specific to each syndrome (Clark & Watson, 1991). Anxious arousal has been
differentiated as a trait-based construct referring to the propensity to experience state fear more
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often and more easily with a temporally stable pattern of hypervigilance between acute fear
responses (Sharp et al., 2015). In women with dysmenorrhea, somatic symptoms are strongly
associated with non-cyclic pelvic pain (i.e., pelvic pain not occurring in relation to menstrual
cycle that lasts over six months), even after the variance associated with depression and anxiety
is accounted for (Latthe et al., 2006). Somatic symptoms are often defined as a physical
condition without an organic cause (Gureje et al., 1998). While some have argued that somatic
symptoms are purely a cognitive or perceptual issue (Eriksen & Ursin, 2004; Ursin, 1997), other
researchers have started to investigate the biological factors that may contribute to the
development and maintenance of somatic symptoms (Rief & Barsky, 2005). Abnormalities in
central nervous system structure and function have been implicated in somatic symptoms,
including the spinal cord, brainstem, somatosensory cortices, parietal cortex, frontal cortex, and
cingulate cortex (Hakala et al., 2002).
In addition to the frequent co-occurrence with somatic symptoms, dysmenorrhea has been
shown co-occur with depression and anxiety symptoms, though the findings have been mixed
(Latthe et al., 2006). Increased depression symptoms are strongly associated with menstrual pain,
and women with dysmenorrhea may have a more negative mood state during menstruation
(Alonso & Coe, 2001; Dorn et al., 2009). Adolescent girls experiencing dysmenorrhea may be at
an increased risk for depression, showing an early predisposition to mood disorders with the
potential for long-term adverse effects (Balık et al., 2014). An extensive body of research
indicates that depression is associated with abnormal patterns of cortical and subcortical brain
function in regional brain networks that overlap with those implicated in pain perception
(Davidson, 1998; Davidson & Irwin, 1999; Heller, 1990; Heller et al., 1997, 1998; Silton et al.,

19
2011). Thus, it remains plausible that the neurobiological correlates of depression and anxiety
symptoms predispose women to a heightened sensitivity to visceral pain perception and/or
dysmenorrhea. Given the study’s primary focus on understanding the role of somatic symptoms
and the substantial overlap in components of anxiety and depression as categorical constructs per
the tripartite model, depression and anxiety will be included as covariates in order to account for
the shared constructs. This will allow our study to focus on the role of somatic arousal symptoms
on pain perception.
Present Study
Psychological symptoms and functional abnormalities in prefrontal and medial frontal
brain activity likely contribute to heightened visceral pain in women with dysmenorrhea.
Developing a better understanding regarding how psychological and physiological mechanisms
confer risk for increased pain perception in women with dysmenorrhea will contribute to
informing the development of effective intervention strategies. In the present study, the
following hypotheses were evaluated in a sample of women with and without a diagnosis of
dysmenorrhea: 1) replicating previous research, women with dysmenorrhea were expected to
have increased somatic symptoms) and report higher levels of pain during experimental bladder
distension, 2) women with greater visceral pain were predicted to have increased resting state
frontal activity, particularly beta activity, and 3) increased frontal activity, particularly beta,
during resting state was expected to be related to increased levels of experimentally-induced
visceral pain in women with dysmenorrhea when variance associated with co-occurring
psychological symptoms was accounted for.
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Method
Female participants were recruited by flyers posted on college campuses, in the
community, Craigslist advertisements, and by referral from local gynecology clinics. Potential
participants were instructed to call a study hotline number and complete a phone screen to
determine eligibility. Participants were not included in this specific study focusing on
dysmenorrhea if they met criteria for other pain conditions. If eligible, participants were
scheduled for an initial screening visit, during which self-report questionnaires on gynecological
history, medical history, and mental health evaluations were administered. The screening visit
was conducted by a board-certified Ob/Gyn with pain fellowship training to verify the likelihood
that participants had primary dysmenorrhea. When necessary, ultrasound evaluation was
performed for further confirmation. Eligible participants completed daily pain diaries to confirm
menstrual pain and they were asked to abstain from using birth control pills for the duration of
the study. Participants were scheduled for a mid-luteal phase assessment session, approximately
17-25 days after commencement of menses. A urinary luteinizing hormone testing kit was used
to confirm entrance into the luteal phase. Participants were asked to avoid taking short-acting,
over-the-counter analgesics (ibuprofen) and caffeine for at least six hours prior to the assessment
session. Data were collected by trained research assistants. At the mid-luteal phase assessment
visit, participants filled out additional questionnaires. At the end of the visit, participants
performed resting state EEG, followed by brief tasks during EEG data collection. Only the
resting state EEG paradigm was analyzed in the present study. The study was approved by the
NorthShore University HealthSystem Institutional Review Board, and informed consent was
obtained from each participant prior to performing any tests or filling out any questionnaires.
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Participants
The present study included N = 130 women (age range:18 - 43, M = 25 years) with
dysmenorrhea (n = 106) and healthy controls (n = 24). The following criteria were used to
identify women with moderate dysmenorrhea: a) average menstrual pain ≥ 50/100 (0 = no pain
and 100 = the worst imaginable pain) during menses or withdrawal uterine bleeding from cyclic
oral contraceptives (OCs) without painkillers, b) menstrual pain in the region between the
umbilicus and the perineum, above the level of the inguinal ligament and c) an indication the
participant has attempted to resolve pain by medical means (including NSAIDs and/or OCs). In
order to be considered a control, women could not be diagnosed with endometriosis or chronic
pelvic pain.
Measures
Demographics
Participants responded to questions about demographic information, including their age
and race/ethnicity (see Table 1).
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Table 1. Demographic Information by Group (N = 130).

Variable
Age, y
Variable
Race
Caucasian
Asian
African American
American Indian/Alaska Native
Multiple Races Reported
Declined to Report
Note: * p <.05

Diagnostic Group
Control
Dysmenorrhea
(n = 24)
(n = 106)
M
SD
M
SD
F
23.04 6.33 24.38 6.18
.91
n
%
n
%
14
8
0
1
0
1

58.3
33.3
0
4.2
0
4.2

64
21
13
0
8
0

p
.34

60.4
19.8
12.3
0
7.5
0

Somatic Symptoms
Participants completed the 6-item somatization subtest from the 18-item Brief Symptoms
Inventory (BSI-18) to evaluate somatic symptoms (Derogatis & Melisaratos, 1983). The BSI is a
widely used self-report questionnaire that consists of eighteen descriptions of physical and
emotional complaints. Respondents are asked to indicate on a 5-point Likert scale from 0 (not at
all) through 4 (very much) to what extent they are troubled by the complaints (Kellett et al.,
2003).
Depression
Participants completed the Patient Reported Outcomes Measurement Information System
short form (PROMIS) to evaluate depression symptoms (α = .98; Bartlett et al., 2015). The
PROMIS depression short-form scale consists of 8 items within a seven-day time frame and a
five-point Likert scale (Cella et al., 2010; Pilkonis et al., 2011). Item content focuses on
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emotional and cognitive manifestations of depression rather than somatic symptoms (e.g.,
fatigue, sleep, appetite). It was developed for use in both clinical and research settings.
Anxiety
Participants also completed the Patient Reported Outcomes Measurement Information
System short form (PROMIS) to evaluate anxiety symptoms (α = .97; Bartlett et al., 2015). The
PROMIS depression short-form scale consists of 8 items within a seven-day time frame and a
five-point Likert scale (Cella et al., 2010; Pilkonis et al., 2011). Item content focuses on fear
(e.g., worry, panic), dread, hyperarousal (e.g., tension, nervousness, restlessness), and somatic
(i.e., arousal) symptoms (e.g., cardiovascular symptoms, dizziness). It was developed for use in
both clinical and research settings.
Procedures
Experimentally Induced Visceral Pain
Participant underwent non-invasive experimental bladder distension (Tu et al., 2012). The
bladder test mimics clinical retrograde cystometry, a diagnostic test used to evaluate bladder
function, starting with an emptied bladder. After oral ingestion of 20 oz of water, participants
were instructed to report when they reached three standard levels of bladder urgency: ﬁrst
sensation, ﬁrst urge to void, and maximal capacity (Abrams et al., 2002). At baseline and each of
these time points, three-dimensional sonographic measurements of the bladder were obtained
(GE Voluson 750, Wauwatosa, WI), and participants rated their bladder pain and urgency on a
10 cm Visual Analog Scale (VAS) on a tablet computer. Experimental bladder pain assessment
was capped at two hours, even if participants did not reach maximal capacity. Experimental
bladder pain scores were determined by participants’ ratings at ﬁrst urge to void.
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Resting State Measurement
Participants were instructed to relax for eight one-minute resting baseline periods during
which EEG data were recorded. Prior to the start of each period, participants saw directions
(counterbalanced “eyes open” or “eyes closed”) on a computer screen. During eyes-open
recording, participants were instructed to focus their eyes on a small cross in the center of the
screen. After each eyes-closed recording, via intercom the experimenter instructed participants to
open their eyes. Per the recommendations of Tomarken et al., (1992) four eyes-open (O) and four
eyes-closed (C) baseline periods, ordered COOCOCCO and OCCOCOOC, were randomly
assigned to the participants.
EEG Data Recording and Collection
Participants were seated in a comfortable chair while EEG data were recorded with active
electrodes using a standard 32-channel cap. Electrode placement was based on the International
10-20 System (Jasper, 1958), with the left mastoid used as the online reference. Eye and facial
movements were also recorded with electrodes placed about the right eye, below the left eye, and
in the middle of the brow in order to account for ocular artifact. Placement of the cap and
electrodes was implemented by a trained research assistant, and impedances were maintained
below 25 kOhms. Data were recorded at a sampling rate of 500 Hz. EEG recordings were
amplified by the actiChamp amplifier (Brainvision, NC) using a 24-bit A/D converter.
Physiological data were collected by Pycorder software (Brainvision, NC). Stimulus presentation
and onset of physiological data collection were controlled by E-prime (Psychology Software
Tools, PA) run on a PC.
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EEG Data Reduction
EEG data were processed in Brain Electrical Source Analysis software (BESA Research
7.0). Visual inspection of the data was implemented to remove ocular and muscular artifacts. In
order to reduce volume conduction contributions, EEG data were transformed to a current source
density (CSD) Laplacian 27-channel virtual montage. CSD is a spatial high-pass filter that is
relatively insensitive to deeper and more distributed sources (Allen & Reznik, 2015; Stewart et
al., 2014). Next, a fast Fourier transform (FFT) was applied to 1.024 second epochs in order to
obtain the power spectrum, producing spectral output in 0.977 Hz bins and then averaging all the
power spectra across epochs within each sixty-second baseline. Spectra were averaged across
eyes-open and eyes-closed baselines in order to allow for stable estimates of oscillatory activity
(Henriques & Davidson, 1991). Alpha (8 – 13 Hz), Theta (4 – 7 Hz), and Beta (14 – 30 Hz)
power was extracted from the power spectrum in 0.977-Hz bins. Lower-1 alpha (6 – 7.5 Hz),
lower-2 alpha (8 – 9.5 Hz), and upper alpha (10 – 13 Hz) were also extracted. Electrode Fz was
selected for analyses as a proxy for frontal activity.
Results
Sample Means and Zero-Order Pearson Correlations
One-way Analysis of Variance Analyses (ANOVA) were conducted to characterize
differences between healthy controls and women with dysmenorrhea on study variables (Table
2). The groups were similar in ages, F (1, 128) = .91, p = .34. Compared to healthy controls,
women with dysmenorrhea reported more sensitivity to visceral pain, and somatic symptoms.
The two groups had comparable levels of depression and anxiety symptoms and were
comparable across frontal resting state activity at different oscillatory bands (e.g., beta, theta,
alpha, and alpha bands).
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Table 2. Group Characteristics of Experimental Bladder Pain, Menstrual Pain, Psychological
Symptoms, and Frontal Resting State Activity.
Diagnostic Group
Control
(n = 24)
M
SD
Experimental Bladder Pain 7.31

8.74

Dysmenorrhea
(n = 106)
M
SD

F (1,128)

p

16.92 12.22

7.49

<.001*

Menstrual Pain

18.21 15.56

72.87 14.36

275.07

<.001*

Depression

14.25 5.19

14.49 6.43

.03

.86

Anxiety

14.54 5.16

15.68 5.96

.75

.39

Somatic Symptoms

1.50

1.50

3.20

3.10

6.82

.01*

Fz Beta Power

-6.48

.41

-6.51

.56

.06

.81

Fz Theta Power

-4.64

.49

-4.69

.57

.18

.68

Fz Alpha Power

-5.28

.58

-5.35

.70

.25

.62

Fz Lower-1 Alpha

-4.83

.62

-4.86

.69

.03

.87

Fz Lower-2 Alpha

-4.98

.65

-5.07

.79

.25

.62

Fz Upper Alpha

-5.53

.61

-5.59

.69

.16

.70

Note: * p <.05
Zero-order Pearson correlation coefficients among variables used in regression analyses
are included in Table 3. Many of the variables were significantly related. As predicted, group
was significantly related to experimental bladder pain (r = .24, p = .01), menstrual pain (r = .83,
p = .00), and somatic symptoms (r = .23, p = .01). Bladder pain was significantly related to
experimental menstrual pain (r = .30, p = .00), somatic symptoms (r = .23, p = .01) and frontal
alpha power (r = .19, p = .03). Menstrual pain was significantly related to somatic symptoms (r =
.22, p = .01). Depression was significantly correlated with anxiety symptoms (r = .80, p = .00)

27
and somatic symptoms (r = .43, p = .00). Anxiety was significantly correlated with somatic
symptoms (r = 0.47, p < 0.01) and frontal beta power (r = .20, p = .02).
Table 3. Correlations Among Group, Pain, Psychological Symptoms, and Brain Activity (N =
130).
1.

2.

3.

4.

5.

6.

1. Group
2. Bladder Pain

.24*

3. Menstrual Pain

.83*

.30*

4. Depression

.02

.05

.08

5. Anxiety

.08

.02

.11

.80*

6. Somatic Symptoms

.23*

.23*

.22*

.43*

.47*

7. Fz Beta Power
8. Fz Theta Power
9. Fz Alpha Power

-.02
-.04
-.04

-.01
.01
.19*

.00
-.01
.04

.17
.06
.14

.20*
.11
.14

.06
.05
.08

10. Fz Lower1 Alpha

-.02

.12

.05

.06

.13

.06

11. Fz Lower2 Alpha

-.04

.20*

.05

.11

.12

.09

12. Fz Upper Alpha

-.04

.16

-.02

.14

.14

.06

Note: *p <.05
Linear Regression
Three hierarchical linear regressions were run to test the hypothesis that somatic
symptoms and frontal resting state activity would be primary predictors of experimental bladder
pain. Group was dummy coded (0 = healthy controls, 1 = dysmenorrhea). The regressions were
each run in five steps. The first step included group, and the second step included other
covariates (depression and anxiety). Somatic symptoms were entered in the third step, and
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frontal resting activity (i.e., beta, theta, alpha) was entered in the fourth step. The fifth step
included the two-way interaction between somatic symptoms x frontal resting activity (Table 4).
Table 4. Hierarchical Linear Regressions of Psychological Symptoms and Brain Activity (Beta,
Theta, Alpha) Predicting Experimental Bladder Pain.
A. Frontal Beta Power
Predictor

B

SE

t (p)

95% CI

Tolerance

VIF

1.00

1.00

R2 = .04,
F(1,128) =
4.84
p = .03*

Step 1

Group

R2

8.05

3.66

2.20 (p =
.03*)

[.81, 15.28]
ΔR2 = .01,
ΔF(2, 126) =
.57
p = 0.57

Step 2

Anxiety

-.40

.41

-.96 (p =
.34)

[-1.21, .42]

.35

2.82

Depression

.41

.39

1.05 (p =
.30)

[-.36, 1.17]

.36

2.81

.73

1.36

.96

1.05

ΔR2 = 0.06,
ΔF(1,125) =
8.03
p = 0.01*

Step 3

Somatic
Symptoms

1.56

.55

2.83 (p =
.01*)

[.47, 2.66]
ΔR2 = 0.00,
ΔF(1,124) =
0.00
p = 0.81

Step 4

Frontal Beta
Power

-.62

2.57

-.24 (p =
.81)

[-5.71,
4.47]
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ΔR2 = 0.00,
ΔF(1,123) =
3.92
p = 0.10

Step 5

Somatic
Symptoms x
Frontal Beta
Power

-.01

.88

-.02 (p =
.99)

[-1.76,
1.76]

t (p)

95% CI

.01

143.83

Tolerance

VIF

1.00

1.00

B. Frontal Theta Power
Predictor

B

SE

R2 = .04,
F(1,128) =
4.84
p = .03*

Step 1

Group

R2

8.05

3.66

2.20 (p =
.03*)

[.81,15.28]
ΔR2 = .01,
ΔF(2, 126) =
.57
p = .57

Step 2

Anxiety

-.40

.41

-.96 (p =
.34)

[-1.21, .42]

.35

2.82

Depression

.41

.39

1.05 (p =
.30)

[-.36, 1.17]

.36

2.81

.73

1.36

ΔR2 = .06,
ΔF(1,125) =
8.03
p = .001*

Step 3

Somatic
Symptoms
Step 4

1.56

.55

2.83 (p =
.01*)

[.47, 2.66]
ΔR2 = .00,
ΔF(1,124) =
.01
p = .91
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Frontal Theta
Power

.28

2.55

.11 (p =
.91)

[-4.77,
5.33]

1.02

.01

74.75

Tolerance

VIF

1.00

1.00

ΔR2 = .01,
ΔF(1,123) =
.72
p = .40

Step 5

Somatic
Symptoms x
Frontal Theta
Power

.98

-.74

.87

-.85 (p =
.40)

[-2.46, .99]

t (p)

95% CI

C. Frontal Alpha Power
Predictor

B

SE

R2 = .04,
F(1,128) =
4.84
p = .03*

Step 1

Group

R2

8.05

3.66

2.20 (p =
.03*)

[0.81,
15.28]
ΔR2 = .01,
ΔF(2, 126) =
.57
p = .57

Step 2

Anxiety

-.40

.41

-.96 (p =
.34)

[-1.21, .42]

.35

2.82

Depression

.41

.39

1.05 (p =
.30)

[-.36, 1.17]

.36

2.81

.73

1.36

ΔR2 = .06,
ΔF(1,125) =
8.03
p = 0.001*

Step 3

Somatic
Symptoms

1.56

.55

2.83 (p =
.01*)

[.47, 2.66]
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ΔR2 = .02,
ΔF(1,124) =
2.95
p = .09

Step 4

Frontal Alpha
Power

3.54

2.06

1.72 (p =
.09)

[-.54, 7.62]

1.03

.02

57.93

Tolerance

VIF

1.00

1.00

ΔR2 = .00,
ΔF(1,123) =
.34
p = .56

Step 5

Somatic
Symptoms x
Frontal Alpha
Power

.98

.39

.67

.58 (p =
.56)

[-.94, 1.72]

D. Frontal Alpha Power Bands
Predictor

B

SE

t (p)

95% CI

R2 = .04,
F(1,128) =
4.84
p = .03*

Step 1

Group

R2

8.05

3.66

2.20 (p =
.03*)

[.81,15.28]
ΔR2 = .01,
ΔF(2, 126) =
.57
p = .57

Step 2

Anxiety

-.40

.41

-.96 (p =
.34)

[-1.21, .42]

.35

2.82

Depression

.41

.39

1.05 (p =
.30)

[-.36, 1.17]

.36

2.81

Step 3

ΔR2 = .06,
ΔF(1,125) =
8.03
p = .001*
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Somatic
Symptoms

1.56

.55

2.83 (p =
.01*)

[.47, 2.66]

.73

1.36

ΔR2 = .03,
ΔF(3,122) =
1.30
p = .28

Step 4

Frontal Lower
Alpha1

-.56

3.13

-.18 (p =
.86)

[-6.77,
5.64]

.43

2.35

Frontal Lower
Alpha2

4.71

3.5

1.35 (p =
.18)

[-2.22,
11.64]

.27

3.69

Frontal Upper
Alpha

1.18

3.14

-.38 (p =
.71)

[-7.40,
5.04]

.43

2.32

Note: *p <.05
As hypothesized, group was a significant predictor of experimental bladder pain, (F (1,
128) = 4.84, p = .03), such that individuals with dysmenorrhea were associated with increased
experimental bladder pain. Further, increased somatic symptoms, (ΔF (1, 125) = 8.03, p = .01)
were a significant predictor of increased experimental bladder pain. Anxiety and depression were
not significant predictors of experimental bladder pain. Further, frontal resting state activity (e.g.,
beta, theta, and alpha power) and the interaction between resting state activity and somatic
symptoms were not significant predictors of bladder pain. A fourth hierarchical linear regression
was run to test the hypothesis that somatic symptoms and frontal alpha power separated into
three bands would be primary predictors of bladder pain; however, the separate alpha power
bands were not significant predictors of experimental bladder pain.
Discussion
The present study sought to replicate previous findings that women with greater
menstrual pain would have increased somatic symptoms and report higher levels of experimental
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bladder pain and also aimed to characterize the neural correlates associated with psychological
symptoms and experimental bladder pain. As expected, women with dysmenorrhea in the study
sample exhibited increased somatic symptoms and experimental menstrual pain compared to
women without dysmenorrhea. However, women with dysmenorrhea were not found to have
increased frontal activity compared to women without dysmenorrhea. Further, dysmenorrhea
diagnosis and increased somatic symptoms predicted accounted for the variance associated with
experimental bladder pain above and beyond other psychological symptoms (e.g., depression or
anxiety) and frontal resting state activity (e.g., beta, theta, or alpha power bands). Of note,
experimental bladder pain was correlated with frontal alpha power, specifically the second lower
alpha band (8 – 9.5 Hz) and anxiety was associated with frontal beta power irrespective of group
membership.
Somatic symptoms and functional abnormalities in prefrontal and medial frontal brain
activity were predicted to contribute to heightened visceral pain in women with dysmenorrhea.
While frontal resting state activity were not significant predictors of experimental bladder pain,
experimental bladder pain was positively correlated with frontal alpha power, particularly in the
second lower alpha band. Developing a better understanding regarding how these mechanisms
confer risk for the development of chronic pelvic pain in these women is imperative in order to
contribute to informing effective intervention strategies. Our results provide evidence that
dysmenorrhea and psychological symptoms are related to increased levels of experimental
bladder pain. Although depression and anxiety were both associated with somatic symptoms in
the present study, neither emerged as a significant factor related to visceral sensitivity.
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Results from hierarchical regressions showed that somatic symptoms were significant
predictors of experimental bladder pain and may be a primary risk factor for the transition to
chronic visceral pain. Somatic symptoms should be considered a key target for psychological
prevention and intervention strategies. While the women in this study were not diagnosed with
chronic pelvic pain, their reports of experimental pain sensitivity were comparable to participants
with chronic pelvic pain in a recent study (Tu et al., 2017). This prior study also confirmed an
important role for somatic symptoms. Thus, the women in the present study may be at risk for
developing the complete profile of symptoms associated with chronic pelvic pain.
Limitations and Future Considerations
Although the present study advanced the characterization of the somatic and
physiological factors associated with visceral pain in women with dysmenorrhea, some
limitations exist. The cross-sectional study design limits our ability to fully understand the
developmental trajectory of pain outcomes in women with dysmenorrhea. In particular, the role
of psychological symptoms (e.g., depression, anxiety) with regard to pain outcomes may be
better understood with longitudinal data, as noted above. Other research has illustrated that
anxiety and depression scores were negatively correlated with beta power, such that enhanced
resting state beta activity was associated with decreased cognitive control, but also less
depressive symptoms in individuals with chronic pain (González-Roldán et al., 2016). While at
first blush this may appear counterintuitive as depression symptoms typically accompany
attentional control deficits (Silton et al., 2011), these findings may be due to a premature
assumption of the emergence of depressive symptoms since clinically significant depressive
symptoms may not have yet emerged in the sample. Further, the present study sample consists
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primarily of young adult women, and developmental data spanning a broad age range would
enhance the generalizability of the results from the present study.
Conclusion
The present study illustrated a relationship between somatic symptoms and visceral pain.
Thus, treatments that reduce somatic symptoms may help ameliorate pain symptoms, such as
mindfulness (Berkovich-Ohana et al., 2012; Travis et al., 2010), transcendental meditation
(Jacobs et al., 1996) and the relaxation-response (Suskind et al., 2014). Notably, mindfulness
exercises have been effective in not only reducing chronic pain, but also decreasing the
likelihood of prolonged somatic symptoms (Kabat-Zinn, 1982). Mindfulness may aid in filtering
inputs to the primary somatosensory cortex, which could broaden attentional resources that may
be narrowly focused on pain and shift that concentration on awareness of the body in a
nonjudgmental way (Kerr et al., 2013). Since chronic pain, depression, and somatic symptoms
are associated with abnormalities in frontocingulate networks, and given the evidence supporting
an association between affect and pain, understanding the multidimensionality of dysmenorrhearelated symptoms from an interdisciplinary perspective is imperative in developing effective
treatments. Continuing to work toward identifying potentially modifiable psychological and
physiological risk factors is critical to ameliorating the development of chronic pelvic pain in the
context of dysmenorrhea.

CHAPTER THREE
CHRONIC PAIN AND INHIBITORY CONTROL IN EMERGING ADULTS: THE ROLE OF
PSYCHOLOGICAL SYMPTOMS
Emerging adulthood (i.e., individuals between the ages of 18-29) is recognized as a
unique period of life characterized by complex developmental transitions (e.g., independence
from caregivers, increased responsibility, complex peer relationships; Arnett, 2014; Stinson et
al., 2014) and distinct neurocognitive and emotional vulnerabilities (Taber-Thomas & PérezEdgar, 2014). Emerging adulthood (also referred to as “young adulthood”), is also a critical
developmental window to optimize self-management strategies (e.g., self-monitoring, evaluation,
reinforcement) to prevent long-term trajectories of severe pain and disability (Blyth et al., 2004;
McCracken & Turk, 2002; Stinson et al., 2014).
Individuals with chronic pain often endorse difficulties with cognitive control that may
impede their ability to effectively engage in pain self-management strategies and achieve salient
educational and vocational milestones (Baker et al., 2016; Berryman et al., 2014). From the
perspective of brain development, emerging adulthood is a vulnerable period of ongoing
maturation of brain networks that implement executive functions (EFs; Taber-Thomas & PérezEdgar, 2014). EFs are interrelated high-level cognitive domains that enable individuals to
navigate day-to-day experiences (Solberg et al., 2009) successfully, and definitions of EFs
generally include aspects of cognitive function such as inhibition, shifting, and updating (Miyake
et al., 2000). These general aspects of functioning are essential for the development of self36
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regulatory processes such as decision making, goal-directed problem solving, selective
attention, and voluntary response inhibition (Blakemore & Choudhury, 2006; Cartwright, 2012;
Liew, \2012; Zelazo, 2015). In terms of self-reported EF abilities, adolescents and middle-aged
adults with chronic pain have endorsed significantly impaired overall EF in daily life contexts
compared to those without chronic pain or standardized norms (Baker et al., 2016; Berryman et
al., 2014; Weiss et al., 2018). However, EF and chronic pain has not been adequately studied in
emerging adults. EF deficits are of particular importance in the context of emerging adults as this
group navigates important transitions (e.g., independent living/self-sufficiency and
educational/vocational choices), and may partially explain why young adults with chronic pain
evidence lower educational and vocational functioning compared to those without chronic pain
(Kashikar-Zuck et al., 2014; Pinquart, 2014).
Among EF domains, inhibitory control may be specifically associated with individuals
experiencing chronic pain. Past studies have found small to moderate impairment in task-related
response inhibition in middle-aged adults experiencing chronic pain (Berryman et al., 2014;
Landrø et al., 2013). Self-reported inhibitory control has also shown small to moderate
impairments (Landrø et al., 2013). Overall, however, findings on inhibition have been mixed,
and task-based and self-reported inhibitory control has not been studied exclusively in emerging
adults. Inhibitory control is defined as the capacity to inhibit or regulate prepotent responses, or
the ability to stop a planned or ongoing thought or action (Williams et al., 1999). Inhibitory
control is required in many activities of daily living in which an individual needs to tune out
stimuli that are irrelevant to a task or process at hand or to the mind’s current state.
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Brain regions that are commonly implicated in pain (e.g., prefrontal cortex (PFC),
anterior cingulate cortex (ACC), and insula; Banich et al., 2020; Shackman et al., 2011) also
overlap with brain regions that support EFs and emotional regulation (Bushnell et al., 2013;
Shackman et al., 2011). Moreover, depression and anxiety peak during the emerging adulthood
period and are commonly co-morbid with chronic pain (Nicholson & Verma, 2004; Richardson
et al., 2012). Thus, it is possible that common psychological symptoms may be associated with
cognitive deficits including inhibitory control impairment in emerging adults with chronic pain.
More broadly, the cognitive demands of chronic pain often involve managing the response to
pain through redirecting attention and inhibiting or suppressing ruminative thoughts about pain
(Solberg et al., 2009). Thus, emerging adults with chronic pain may be particularly vulnerable to
perceiving deficits in inhibitory control function due to the underlying influence (i.e., mediating
effects) of heightened psychological symptomatology. By characterizing psychological factors
that maintain inhibitory deficits, future studies can aim to develop more effective treatments for
emerging adults with chronic pain.
The present cross-sectional study had two aims. First, we report on several pain
characteristics in an emerging adult population (current sample’s age ranges from 18-27), for
which there is little pain research. Specifically, we report on pain location, frequency, intensity,
duration, bother, and activity limitations due to pain. Next, we evaluated the mediating influence
of psychological symptoms on the relation between chronic pain status and perceived inhibitory
control function (see Figure 1). Participants were coded as having chronic pain if endorsing pain
lasting 3 months or longer on this item, which is in line with the International Association for the
Study of Pain (IASP) definition of chronic pain (Merskey & Bogduk, 1994). For this aim, we
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utilized a parallel mediation model with cross-sectional data. Given the overlap of pathways
previously discussed, we hypothesized that psychological distress would influence the relation
between chronic pain status and self-reported inhibitory control. Of note, age, gender, ethnicity,
and race all have been linked to differences in pain, psychological symptoms, and inhibitory
control (Affleck et al., 1999; Campbell et al., 2008; Riley et al., 2002; Tsang et al., 2008;
Williams et al., 1999; Yuan et al., 2008). In order to account for differences associated with these
constructs, which are not associated with the primary aims of this study, they will be included as
covariates in the model.
Method
Participants
Emerging adults (N = 2481) enrolled in an urban Midwestern university were recruited
from introductory psychology courses between the years of 2014 - 2019. Participants completed
online questionnaires in a single session measuring psychological symptoms (e.g., depression,
anxiety, and pain symptoms). These surveys were part of a larger battery of self-report
questionnaires. Casewise deletion was used to omit participants (n = 31) who did not fit within
the emerging adult age range (ages 18-29) as well as participants (n = 105) who had missing
responses to any questionnaires used in the present study. The final sample used for analyses
included 2345 participants between the ages of 18 – 27 years. The study was approved by the
University’s Institutional Review Board, and informed consent was provided to all participants
before beginning the survey.
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Measures
Demographics
Participants responded to questions about demographic information, including questions
about age, gender, race, and ethnicity.
Chronic Pain Status
Participants reported on overall pain duration (e.g., how long they had aches or pains; 0
= “Not at all,” 1 = “less than one month,” 2 = “1 to 2 months” or 3 = “3 months or longer”).
Participants were coded as having chronic pain if endorsing pain lasting 3 months or longer on
this item, which is in line with the IASP definition of chronic pain (Merskey & Bogduk, 1994).
Those without chronic pain endorsed a 0, 1 or 2 on a 4-point frequency scale.
Pain Characteristics
Participants reported on additional pain characteristics including location, frequency,
intensity, daily duration, bother/upset due to pain, and activity limitations due to pain.
Individuals also indicated the location(s) they experienced pain (i.e., “Where on your body do
you have aches or pain?”). Emerging adults further reported on pain frequency (i.e., “In the past
month, how often have you had aches or pains?”) using a 7-point Likert rating scale (0 = “not at
all” to 6 = “daily”; Toliver-Sokol et al., 2011). Participants also rated their usual pain intensity
(i.e., “When you have aches or pains, how much hurt do you usually have?”) using an 11-point
Numerical Rating Scale (0 = “no pain” to 10 = “worst pain possible”), which has demonstrated
adequate reliability and validity (Dworkin et al., 2005; von Baeyer, 2009), daily pain duration
(i.e., “How long do your aches usually last?”) was rated on a 4-point scale (1 = “less than an
hour” to 4 = “all day”; Toliver-Sokol et al., 2011). Participants also rated how bothersome they
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found their pain (i.e., “How much do aches or pains bother or upset you?) was rated on a 5-point
scale (1 = “not at all” to 5 = “very much”; Holley et al., 2017; McGrath, 1993; von Baeyer et al.,
2009). Finally, participants provided information on activity limitations (i.e., “How much do
aches or pains limit or stop you from doing usual activities?”) using an 11-point Numerical
Rating Scale (0 = “does not limit activity” to 10 = “limits all activity”; Dworkin et al., 2005; von
Baeyer, 2009).
Affectivity and Anxious Arousal Symptoms
The Mood and Anxiety Symptoms Questionnaire (MASQ) was used to assess depression
and anxiety components of the tripartite model (Watson, Clark, et al., 1995; Watson, Weber, et
al., 1995). The following 3 subscales were used in this study: 8-item Negative Affectivity (NA)
scale, 14-item Positive Affectivity (PA) scale, and 17-item Anxious Arousal (AA) scale. Higher
scores reflect greater levels of symptomatology. McDonald’s Omega was obtained for each
subscale in a study utilizing a sample of patients with chronic pain that supported the utility of
the MASQ with this population, which are consistent with the original validation sample
showing moderate to high internal consistency across all three subscales (Geisser et al., 2006).
The present study replicated these findings (NA, ω = .81; PA, ω = .93; and AA, ω = .88).
Worry
The Penn-State Worry Questionnaire was used (Meyer et al., 1990). The PSWQ has 16
items and each item is rated on a scale from 1 (“not at all typical of me”) to 5 (“very typical of
me”). Eleven items are worded in the direction of pathological anxious apprehension (i.e.,
worry), with higher numbers indicating more anxious apprehension (e.g., “Once I start worrying,
I cannot stop”), while the remaining five items are worded to indicate that anxious apprehension
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is not a problem, with higher numbers indicating less anxious apprehension (e.g., “I never worry
about anything”). The total score was calculated by summing the first 11 items and the reversescores of the latter 5 items, with higher PSWQ scores reflecting greater levels of pathological
anxious apprehension. Consistent with previous research (Henning et al., 2007), the present
study found good internal consistency (ω = .94).
Inhibitory Control
The eight-item inhibition clinical scale subtest from the Behavior Rating Inventory of
Executive Function – Self Report (BRIEF-A) was used to assess inhibitory control function and
has been used to assess executive function in both children (through caregiver report) and adults
with chronic pain (Baker et al., 2016; Gioia et al., 2000; Hocking et al., 2011). Participants
indicate the extent to which a variety of behaviors (e.g., “I have trouble concentrating on tasks”)
have been a problem (N = Never, S = Sometimes, O = Often). Internal consistency has been
shown to be in the moderate range (Gioia et al., 2000) and the present study replicates these
findings (ω = .77).
Data Analyses
All analyses were conducted with SPSS version 26.0. Descriptive statistics were
calculated for continuous (e.g., pain intensity) and categorical (e.g., pain location) pain
characteristics. Associations among the four pain characteristics (i.e., chronicity, one-month
frequency, intensity, and duration), psychological symptoms (i.e., affectivity and anxiety), and
inhibitory control were examined using Pearson two-tailed correlations. Finally, a parallel
mediation analysis was conducted using the PROCESS v3.4 macro in SPSS (Hayes, 2017) to
evaluate which psychological symptoms (positive affectivity, negative affectivity, anxious
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arousal, and anxious apprehension (i.e., worry)) distinctly mediate the relationship between
chronic pain status (chronic pain and no pain) and inhibitory control. Because age, gender,
ethnicity, and race have been linked to differences in pain, psychological symptoms, and
inhibitory control (Affleck et al., 1999; Campbell et al., 2008; Riley et al., 2002; Tsang et al.,
2008; Williams et al., 1999; Yuan et al., 2008), all four were entered as covariates in the model.
Power Analysis
A sensitivity power analysis with a two-tailed significance level of p < .05 (Aiken et al.,
1991; Cohen & Servan-Schreiber, 1992) was used to determine an appropriate effect size given
our study’s sample size using parallel mediation analysis (Cohen, 1988). The sensitivity power
analysis was conducted in G*Power 3.1.9.2 (Faul et al., 2007) to test parallel mediation. With a
sample size of 2345 participants and an alpha of .05, results showed that a minimum effect size
of R2 = .008 is needed to achieve power of 80% for a mediation analysis with four mediators
(i.e., NA, PA, AA, anxious apprehension) and four covariates (i.e., age, gender, ethnicity, race).
Results
Characteristics of the Study Sample
Participants included 2345 emerging adults ages 18 to 27 years (mean age = 18.95 SD =
1.07). The majority of the full sample was female (74.4%; N = 1744). As shown in Table 5,
approximately 18% (n = 419) of the total sample endorsed chronic pain. In addition, in the past
month pain occurred one to three times per week for approximately 40% of the total sample (n =
932), and 5.6% reported experiencing daily pain. Pain in the past month usually lasted a few
hours to half the day for about one third (29.0%; n = 681) of young adults. Common pain
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locations included the back (n = 533; 22.7%), extremities (i.e., shoulders, ankles, knees; n = 472;
20.1%); and head/neck (n = 470; 20.0%).
Table 5. Demographic Information by Group (N = 2345).

Variable

Group
Non-Chronic Pain Chronic Pain
(n = 1926)
(n = 419)
M
SD
M
SD

Age (years; range = 18-27)
Variable

18.95
N

1.07
%

18.94
N

1.08
%

.85a

Female
Ethnicity
Hispanic/Latino
Race
American Indian/Alaska Native
Asian
Native Hawaiian/Pacific Islander
African American
Caucasian
Multiple Races Reported
Did Not Report

1395

72.4

349

83.3

<.001b
.71b

287

14.9

65

15.5

p

<.001b
12
416
17
86
1226
98
71

.6
21.6
.9
4.5
63.7
5.1
3.6

1
42
3
13
323
24
13

.2
10.0
.7
3.1
77.1
5.7
3.2

Note: Significance (p-value) after Bonferroni corrections in demographics across groups were
evaluated with a t-test as designated by a or Χ2 as designated by b.
For individuals specifically reporting chronic pain (n = 419; Table 6), pain occurred one
to three times per week for approximately 72% of the sample (n = 303), and 25% reported
experiencing daily pain. In addition, pain usually lasted a few hours to half the day for over half
(57.1%; n = 239) of young adults experiencing chronic pain, while 20.5% of the sample reported
pain lasting the entire day. To evaluate differences in pain intensity, bother, and activity
limitations among the two groups (non-chronic pain and chronic pain), Bonferroni-corrected
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two-tailed independent sample t-tests were conducted to compare the group means. Individuals
in the chronic pain group reported significantly more usual pain intensity, bother due to pain, and
activity limitations due to pain (ps <.05) relative to the non-chronic pain group (Table 6).
Table 6. Group Characteristics of Pain, Psychological, and Inhibitory Control Variables.
Group
Non-Chronic Pain
(n = 1926)

Chronic Pain
(n = 419)

Variable
Pain Location
None Listed
Back
Head/Neck
Arms/Shoulders, Legs
Stomach/Abdomen
Chest/Lung
Generalized

n
1133
320
310
292
110
66
27

%
58.8
16.6
16.1
15.2
5.7
3.4
1.4

n
10
213
160
82
40
27
13

%
2.4
50.8
38.2
19.6
9.5
6.4
3.1

Pain Prevalence

n

%

n

%

1791
135
--

93.0
7.0
--

--419

--100.0

1171
464
228

60.8
24.1
11.8

11
75
165

2.6
17.9
39.4

31
26
6

1.6
1.4
0.3

63
105
0

15.0
25.1
0

815
328

42.3
17.1

93
149

22.2
35.6

Chronicity
Less than one month
1-2 months
3 months or longer
One-Month Frequency
Not at all
1 time per week
2-3 times per week
4-6 times per week
Daily
No Response
Duration
<1 hour
A few hours
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Half the day
All day
No Response
Pain Intensity
Pain Bother
Activity Limitations

Positive Affectivity (PA)
Negative Affectivity (NA)
Anxious Arousal (AA)
Anxious Apprehension
(APP)
Inhibitory Control (IC)

114
66
603

5.9
3.4
31.3

90
86
1

21.5
20.5
.2

n (%)

M (SD)

n (%)

M (SD)

p

1629
(69.4)
1659
(70.7)
1638
(69.9)
n (%)

3.46 (2.36)

418 (17.8)

5.77 (1.86)

<.001*

1.81 (0.90)

418 (17.8)

2.71 (0.86)

<.001*

2.38 (2.07)

419 (17.8)

3.77 (2.30)

<.001*

M (SD)

n (%)

M (SD)

p

1926
(82.1)
1926
(82.1)
1926
(82.1)
1926
(82.1)
n (%)

43.89
(11.32)
18.35 (6.03)

419 (17.9)

41.72
(12.06)
19.76 (6.11)

<.001*

29.58
(10.35)
55.57
(13.93)
M (SD)

419 (17.9)

<.001*

n (%)

33.34
(11.31)
59.09
(14.09)
M (SD)

1926
(82.1)

13.92 (3.23)

419 (17.9)

14.65 (3.08)

<.001*

419 (17.9)

419 (17.9)

<.001*

<.001*
p

Note: *p <.05
Correlations Among Pain, Psychological Health, and Executive Function
Pearson correlations were computed among the primary study variables (Table 7).
Positive affectivity, negative affectivity, anxious arousal, anxious apprehension, and inhibitory
control were significantly associated across the study sample (ps < .05).
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Table 7. Correlations Among Affectivity and Inhibitory Control (N = 2345).
1.

2.

3.

4.

1. Positive Affectivity (PA)
2. Negative Affectivity (NA)

-.39

3.Anxious Arousal (AA)

-.08

.60

4. Anxious Apprehension (APP)

-.25

.40

.28

5. Inhibitory Control (IC)

-.08

.38

.40

.19

Note. All shown correlations were significant (ps <.05)
PA = Positive Affectivity, NA = Negative Affectivity, AA = Anxious Arousal, APP = Anxious
Apprehension, IC = Inhibitory Control
Psychological Symptoms and Inhibitory Control
To evaluate differences in psychological and inhibitory control symptoms among the two
groups (non-chronic pain and chronic pain), two-tailed independent sample t-tests were
conducted to compare the group means. Analyses comparing psychological symptoms
(affectivity and anxiety) between the chronic pain and non- chronic pain groups revealed that
individuals in the chronic pain group reported significantly more anxious arousal, negative
affectivity, and anxious apprehension, as well as significantly less positive affectivity (ps < .05;
Table 6), relative to those without chronic pain. The chronic pain group also reported
significantly more inhibitory control difficulties compared to the no pain group (Table 6).
Parallel Mediation Analysis
A parallel mediation analysis (Figure 1) was conducted to evaluate whether self-reported
psychological symptoms influenced the relation between chronic pain and inhibitory control
deficits in individuals experiencing chronic pain. The model examined the effects of pain group
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(non-chronic pain vs. chronic pain) mediated by psychological symptoms (positive affectivity,
negative affectivity, anxious arousal, and anxious apprehension) on inhibitory control.
Age, gender, ethnicity, and race were included as covariates in the model (Table 8). In
terms of these demographic covariates, gender was associated with positive affectivity, negative
affectivity, and anxious apprehension, such that women were found to have higher levels of
negative affectivity and anxious apprehension and lower levels of positive affectivity (ps < .05).
Gender was not associated with anxious arousal. Older age was associated with higher levels of
anxious apprehension and lower levels of positive affectivity (ps < .05). Race and ethnicity were
not associated with psychological symptoms.
Regressions showed that pain group was associated with positive affectivity (path a1 = 1.94, p <.05), negative affectivity (path a2 = 1.23, p < .05), anxious arousal (path a3 = 3.47, p <
.05), and anxious apprehension (path a4 = 2.36, p < .05) symptoms (Table 8). Chronic pain status
(c’ = .28, p = .09) was not directly significantly associated with inhibitory control when
accounting for variance in demographic and psychological variables, indicating that individuals
with chronic pain did not report higher levels of inhibitory control difficulties independent of
variance associated with psychological symptoms. However, pain group was indirectly
associated with inhibitory control via multiple pathways: positive affectivity, negative
affectivity, and anxious arousal (ps < .05). 95% bootstrap confidence intervals based on 5,000
bootstrap samples were calculated for indirect effects. The 95% confidence intervals for the
indirect effects of positive affectivity (95% CI [-.059, -.001], a1b1 = -.03), negative affectivity
(95% CI [.066, .237], a2b2 = .15), and anxious arousal (95% CI [.167, .382], a3b3 = .268) did not
include zero. Anxious apprehension was not associated with inhibitory control (b4=.01; p =.10),
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and the 95% confidence interval for the indirect effect for anxious apprehension (95% [-.005,
.052], a4b4 = .019) included zero.
Thus, the indirect relation among pain group and inhibitory control was mediated via
positive affectivity, negative affectivity, and anxious arousal, but not anxious apprehension.
Because the direct pathway between chronic pain status and inhibitory control was nonsignificant, these findings primarily implicate indirect mediation pathways (Lennon et al., 2015;
Zhao et al., 2010).
Figure 1. Structural Diagram of Parallel Multiple Mediator Model. Four mediators (PA =
positive affect, NA = negative affect, AA = anxious arousal, and anxious apprehension) with
pain group (non-chronic pain vs. chronic pain) as the predictor. Black arrows specify significant
pathways while gray arrows represent insignificant pathways. The diagram shows 1) the total
effect of group on inhibitory control and 2) the direct effect and causal pathways associating
group with inhibitory control.

PA
NA
Pain
Group
Covariates:
Gender
Age
Ethnicity
Race

c' = 0.28

Inhibitor
y Control

AA
APP

Note. PA = Positive Affectivity, NA = Negative Affectivity, AA = Anxious Arousal, APP =
Anxious Apprehension, IC = Inhibitory Control; *ps < .05

Table 8. Unstandardized Model Coefficients for the Parallel Mediation Analysis (as described in Figure 1).

Note. PA = Positive Affectivity, NA = Negative Affectivity, AA = Anxious Arousal, APP = Anxious Apprehension, IC = Inhibitory
Control, GEN=Gender, ETH = Ethnicity
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Discussion
Our study provides initial evidence of impaired inhibitory control and its association with
psychological symptoms in an emerging adult sample that has a substantial amount of chronic
pain. Of note, 18% of the emerging adults in the present study reported chronic pain symptoms
for three or more months, and this chronic pain prevalence is within the range of prevalence rates
reported in epidemiological studies (7.6-21%; Eriksen et al., 2003; Iversen et al., 2017; Kennedy
et al., 2014; Mallen et al., 2006; Rosenbloom et al., 2017; Stinson et al., 2013). In the present
study, emerging adults with chronic pain reported increased psychological symptomatology that
was associated with self-reported inhibitory control. Psychosocial interventions that target
affectivity and anxious arousal symptoms may improve function in emerging adults with chronic
pain.
Regarding psychological symptoms reported in our sample, results replicated previous
research (Bayram & Bilgel, 2008; Eisenberg et al., 2007; McGorry et al., 2011) and supported
our hypothesis that increased pain levels were associated with increased psychological
symptoms. In general, chronic pain was associated with higher levels of negative affectivity,
anxious apprehension, and anxious arousal, as well as lower levels of positive affectivity.
However, results from our exploratory parallel mediation analysis showed that only negative
affectivity, positive affectivity, and anxious arousal mediated the indirect relation between pain
group and inhibitory control. Notably, anxious apprehension was not a significant mediator
indicating that with regard to anxiety symptoms, anxious arousal may be distinctly related to
cognitive outcomes for individuals with chronic pain. Anxious arousal has been identified as a
trait-based propensity to experience state fear more often and more easily with a temporally
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stable pattern of hypervigilance between acute fear responses while anxious apprehension is
theorized to better represent state anxiety in response to an acutely threatening situation (Sharp et
al., 2015). The experience of co-morbid chronic pain and psychological distress in emerging
adults may increase the risk for impaired cognitive function, with negative consequences for
daily life function. Similar brain regions (e.g., PFC, ACC, insula) have been implicated in pain,
inhibitory control, and emotional regulation (Bushnell et al., 2013; Shackman et al., 2011). Thus,
difficulties regulating inhibitory control may be exacerbated by the added challenges of
psychological symptoms in emerging adults experiencing chronic pain. Further, the onset of
internalizing symptoms (i.e., withdrawal, somatic symptoms, and anxiety/depression) has been
shown to peak during the adolescent and emerging adulthood, and thus emerging adults as a
group may be particularly vulnerable to experiencing elevated levels of depression and anxiety
(Bayram & Bilgel, 2008; Eisenberg et al., 2007; Hysenbegasi et al., 2005; McGorry et al., 2011;
Paul & Brier, 2001).
Interventions that aim to reduce the cognitive burden associated with chronic pain by
specifically focusing on reducing anxious arousal and negative affectivity and increasing positive
affectivity may improve overall inhibitory control function. Such interventions may dramatically
improve the quality of life of emerging adults experiencing chronic pain. Further, promoting
interventions that focus on reducing the cognitive and emotional burden of chronic pain in
emerging adults may improve long-term functional and health outcomes for which this age group
may be particularly vulnerable (e.g., opioid misuse and abuse; Atluri et al., 2014; Birnbaum et
al., 2011; O’Brien et al., 2017; Vowles et al., 2015). Mindfulness has recently been a target of
intervention study for chronic pain due to its specific attention to reducing somatic symptoms
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and stress (Kerr et al., 2013; Morone et al., 2008; Rosenzweig et al., 2010; Zeidan & Vago,
2016). More recently, techniques incorporating standardized mindfulness practices have been
hypothesized to make available attentional resources that were once pain-focused in individuals
with chronic pain and provide a framework for potential interventions (Kerr et al., 2013).
Moreover, cognitive-behavioral therapy (CBT) is another highly effective treatment of chronic
pain. CBT for chronic pain incorporates several techniques that reduce pain and distress in
adults, including deep breathing, progressive muscle relaxation, and thought restructuring (Ehde
et al., 2014). Overall, further research is needed to understand how psychological interventions
may be tailored to the unique developmental needs of emerging adults.
Limitations and Future Directions
While this study has several notable strengths, several questions remain. The results from
the present study are based solely on self-report measures of inhibitory control. Future research
should focus on experimental measures of inhibitory control in order to assess the implications of
chronic pain and psychological symptoms on this domain of cognitive control. Additionally, the
present study is limited by its cross-sectional design, which precludes unequivocal conclusions
about cause and effect. While some researchers have advocated against this practice since
correlational data do not afford causal interpretation (Maxwell et al., 2011), Hayes advocated for
this position: “We should not let the limitations of our data collection efforts constrain the tools
we bring to the task of trying to understand what our data might be telling us about the processes
we are studying” (p. 18; Hayes, 2017). Many researchers share this sentiment as indicated by
their use of mediation analyses with cross-sectional data (Blashill & Vander Wal, 2010; Gaunt &
Scott, 2014; Goodin et al., 2009; Kung et al., 2016; Lee et al., 2014; Li et al., 2011; Osborne et
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al., 2015; Rees & Freeman, 2009; Schaie, 2005; Smith et al., 2016; Thai et al., 2016; Thomas &
Bowker, 2015; Torres & Taknint, 2015; Webb et al., 2016). Thus, this study represents a critical
first step in delineating associations that in future work could be examined as a potential
mechanism influencing the link between chronic pain and executive dysfunction. These
associations should be replicated in micro-longitudinal (experience sampling) designs or
experimental pain paradigms. Although a unique aspect of this study is that the emerging adult
sample are all college-attending young adults with chronic pain, many adolescents with chronic
pain may not transition to college or drop out early due to the burden of chronic pain (Murray et
al., 2020). Thus, it is unknown whether these results are more pronounced in non-college
attending emerging adults with perhaps more severe and disabling chronic pain.
Conclusions
Overall, the results of this study indicate that chronic pain was associated with
increased perceived inhibition impairments and results from a parallel mediation analysis
showed a significant indirect effect between chronic pain status and perceived inhibition
impairments via negative affectivity, positive affectivity, and anxious arousal. Future research
can extend these results by examining longitudinal trajectories to expand our understanding of
the impact of chronic pain on executive function deficits in emerging adults, including the key
role of psychological symptoms in driving this association. Moving forward, it appears critical to
develop effective evidenced-based interventions that target specific dimensions of psychological
symptoms to improve the quality of life in individuals with chronic pain disorders.

CHAPTER FOUR
ANXIOUS AROUSAL AND ANXIOUS APPREHENSION ARE DISTINCTLY RELATED
TO THE TEMPORAL COURSE OF RESPONSE INHIBITION
Successfully navigating day-to-day experiences through goal-directed behavior is
dependent upon intertwined healthy emotional and cognitive processes. Anxiety is associated
with numerous cognitive impairments and biases that often impede quality of life and the ability
to successfully carry out activities of daily living. Both state and trait anxiety symptoms
negatively impact a range of cognitive processes, including impaired inhibitory control functions
(Banich et al., 2009; Engels et al., 2007; Notebaert et al., 2018; Toh & Yang, 2020; Warren et
al., 2013). Since emotional information is often prioritized during information processing
(Stockdale et al., 2020), the ability to exert control over automatic reactivity to emotional
information is paramount to salubrious affective function. Notably, abnormalities in emotion
reactivity and regulation processes are present across various types of psychopathology,
including anxiety and depression (Pessoa & Ungerleider, 2004; Sharp et al., 2015).
More specifically, anxiety symptoms are associated with increased selective attentional
bias for threat, decreased attentional control capacity in the context of emotional stimuli, and the
impaired ability to suppress behaviors that are inappropriate in a given context that interfere with
goal-driven behavior (Bar-Haim et al., 2007;
Derryberry & Reed, 2002; Pacheco-Unguetti et al., 2012; Sass et al., 2010). Response inhibition,
or the ability to withhold automatic responses that are not task-relevant (Mostofsky &
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Simmonds, 2008), is important to carrying out daily life activities in an effective manner.
Response inhibition is implemented by a network of brain regions including dorsomedial and
lateral PFC, right inferior frontal cortex, and dorsal anterior cingulate cortex (dACC; Aron et al.,
2014; Banich et al., 2009; Miller & Cohen, 2001; Silton et al., 2010). Previous research has
shown that distinct dimensions of anxiety symptoms (e.g., anxious arousal and anxious
apprehension) are disruptive to inhibitory control processes, including response inhibition
(Engels et al., 2007, 2010; Guha et al., 2020; Sharp et al., 2015; Silton et al., 2011; Warren et al.,
2013; Williams et al., 1999). Understanding how anxious arousal and anxious apprehension are
uniquely associated with the temporal course of the neural correlates of response inhibition is
paramount to developing effective treatment methods that can target and modify specific anxiety
symptom subtypes.
Anxious arousal is marked by sympathetic hyperarousal and hypervigilance in the
presence of mild stressors (Heller et al., 1997; Nitschke et al., 2000; Sharp et al., 2015; Watson,
2005). Anxious arousal refers to a trait-based propensity to experience state fear more often and
more readily with a temporally stable pattern of hypervigilance between acute fear responses
(Sharp et al., 2015). Anxious arousal is associated with increased sensitivity to distracting and
mildly threatening stimuli, which in turn appears to impact attentional networks via an overactive
engagement of bottom-up attention (e.g., attention guided by externally driven factors; Spielberg
et al., 2013). Thus, anxious arousal may be associated with abnormalities in response inhibition
due to tonic levels of heightened arousal in response to frequently perceiving exteroceptive and
interoceptive stimuli as noxious.
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While some studies have used descriptors such as “worry” or “fear” to characterize
anxious arousal, these terms are theorized to better represent state anxiety in response to an
acutely threatening situation and are distinguished as anxious apprehension (Sharp et al., 2015).
Anxious apprehension is conceptualized as a persistent pattern of engaging in negative, repetitive
thinking about (both proximal and distal) perceived threats, which also can be thought of as an
enduring pattern of state worry (Engels et al., 2007; Ruscio et al., 2001). In threating situations,
individuals high in anxious apprehension appear to immediately engage neural networks that
implement worry, leading to a reduced initial threat response (Sharp et al., 2015). Anxious
apprehension may hinder the ability to inhibit negative, maladaptive thinking patterns which in
turn appears to impact attentional networks via an interference with top-down attentional control
(i.e., attention guided by internal factors) and adaptive conflict resolution in the context of both
negative affective distractors as well as irrelevant stimuli in Stroop paradigms without affective
distractors (Engels et al., 2007, 2010; Guha et al., 2020; Herrington et al., 2010; Silton et al.,
2011), suggesting a more general impairment in inhibitory control processes (Sharp et al., 2015).
Anxious Arousal and Anxious Apprehension are Characterized by Distinct Patterns of
Neural Activity
Anxious arousal has been characterized by greater right hemisphere activity, primarily in
lateral frontal areas in functional Magnetic Resonance Imaging (fMRI) studies (Nitschke et al.,
1999), although also involving temporal and parietal regions that are involved in hypervigilance,
attentional biases, and dispositional tendencies (Burdwood et al., 2016; Compton et al., 2003;
Engels et al., 2007; Nitschke et al., 1999). Specifically, anxious arousal has been associated with
activity in right inferior temporal gyrus (ITG) and middle temporal gyrus (MTG), both of which
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are thought to implement threat detection (Engels et al., 2007; Nitschke et al., 2000; Spielberg et
al., 2013). High anxious arousal was related to hyperactivity in these temporal regions while
attempting to ignore negatively valanced words, indicating a lower threshold to engage in a statebased fear response when exposed to mildly threatening stimuli. Results from the Engels et al.,
(2007) study showed that negative emotional words evoked greater right-hemisphere
temporoparietal activity specific to individuals with high trait anxious arousal. These results are
consistent with the theory that the right hemisphere houses an integrated system for responding
to threat, promoting sympathetic nervous system activity, spatial attention, visual scanning of the
environment, and sensitivity to meaningful nonverbal cues (Compton et al., 2003; Engels et al.,
2007; Keller et al., 2000). In the Engels et al. (2007) study, the anxious arousal group showed
less frontal activity than the control group from medial PFC extending into rostral anterior
cingulate cortex (rACC), which is consistent with brain regions that are associated with specific
event-related potentials (ERPs; N200 and N450) that are observed during a range of cognitive
control tasks (Engels et al., 2007; Hanslmayr et al., 2008; Liotti, Woldor, et al., 2000; Szűcs et
al., 2009), and are discussed in more detail below. Further, individuals with high anxious arousal
have shown early engagement of a threat response system, evidenced by activity in right superior
frontal gyrus (SFG), ITG, and MTG that habituated over time (Sharp et al., 2015).
Anxious apprehension is primarily implemented in neural circuits that specialize in
language production and verbal working memory (Engels et al., 2007, 2010; Nitschke et al.,
1999, 2000). Engels and colleagues (2007) found left inferior frontal gyrus (IFG; i.e., Broca’s
area) activity was related to biased processing of negative information in individuals with
anxious apprehension, such that activation of left IFG was only observed when contrasting
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negatively valanced stimuli to neutral stimuli. It has also been surmised that left IFG is activated
in individuals high in anxious apprehension due to the rehearsal of task rules via articulation,
which has been shown via increased activity in left IFG in verbal working memory tasks
(Paulesu et al., 1993). Further, a recent study by Guha and colleagues (2020) revealed that
greater connectivity from Broca’s area to amygdala during tasks requiring greater cognitive
control. Findings revealed that greater connectivity may serve as a compensatory mechanism by
which individuals high in anxious apprehension may engage in successful compensation for
interference effects while employing inhibitory control (Guha, 2020). Related, anxious
apprehension was associated with modulated activity in a frontocingulate network, with earlier
left DLPFC (300 – 440) activity preceding later dACC activity (520 – 680 ms) during a cognitive
Color-Word Stroop Task (CWST), with increased later dACC activity thought to reflect a
compensatory mechanism for an initial failure in earlier top-down control of attention
implemented by DLPFC for individuals high in anxious apprehension (Sharp et al., 2015; Silton
et al., 2011).
A critical caveat is that with the exception of Silton et al. (2011), nearly all of the
reviewed extant literature regarding the neural correlates of anxious arousal and anxious
apprehension was conducted using attentional control paradigms with affective stimuli and/or
fMRI methods. Although these studies are paramount to advancing our understanding of anxiety
subtypes, they provide minimal insight regarding how these anxiety subtypes might influence the
precise temporal course of response inhibition implemented in an experimental context that does
not include affective stimuli (e.g., emotion words or images). Thus, while anxious arousal may
distinctly impact brain regions related to earlier bottom-up processing and anxious apprehension
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may interfere with brain regions associated with later top-down control functions, these findings
may be specific to attentional control tasks with affective stimuli. In order to evaluate how
anxiety subtypes influence the temporal course of response inhibition that is not mitigated by
affective stimuli, the present study was conducted with a traditional cognitive Color-Word
Stroop Task (CWST) using incongruent/congruent color words and neutral word stimuli.
The Temporal Course of Neural Activity during Inhibitory Control Processes
A number of electrophysiological and functional imaging studies have implicated several
brain regions during response inhibition, including ACC, DLPFC, posterior parietal cortex, and
inferior parietal cortex (Egner et al., 2007; MacLeod & MacDonald, 2000; Peterson et al., 2002;
Silton et al., 2010; van Veen & Carter, 2005). Notably, many of these brain regions overlap with
patterns of abnormal brain activity observed in individuals with anxious arousal (Engels et al.,
2007; Nitschke et al., 2000; Spielberg et al., 2013). EEG methods, including event-related
potentials (ERPs), offer precise temporal resolution to characterize the rapid succession of neural
events that occur during response inhibition, particularly with regard to resolving stimulus
interference. While several ERP components have been associated with interference (i.e., slower
response time to incongruent than congruent color word stimuli) on the CWST, findings suggest
that additional research is needed to resolve the precise time course of neural processes observed
in the CWST (Coderre et al., 2011; Galer et al., 2014). Previous research investigating the time
course of inhibitory control processes evoked by the CWST has generally included the N200,
N450, and conflict SP components. While prior research has addressed the influence of anxious
arousal specifically on the recruitment and allocation of neural resources during emotion
interference processing using state-based threatening information (Engels et al., 2007, 2010;
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Guha et al., 2020), the present study investigated the influence of anxious arousal on the three
most established ERP components (N200, N450, and conflict SP) observed during response
inhibition on the CWST.
N200
The N200 (a negative deflection with a peak latency approximately 200 to 250 ms
following the stimulus presentation) has been observed in CWST paradigms (Holmes &
Pizzagalli, 2008; Silton et al., 2010) as well as in other visual interference and response
inhibition tasks that involve monitoring for stimulus conflict (Folstein & Van Petten, 2008; Kopp
et al., 1996; Yeung et al., 2004). Relevant to the CWST, some studies have shown that the N200
differentiates between incongruent and congruent trials, with greater negative amplitude for
incongruent than congruent conditions (Folstein & Van Petten, 2008; Holmes & Pizzagalli,
2008; Kopp et al., 1996; Silton et al., 2010; Yeung et al., 2004). This negative, frontally
distributed component is thought to be generated by inferior/lateral PFC or dACC (Jackson et al.,
2001; Kiefer et al., 1998). The N200 has been related to the detection of perceptual novelty,
response conflict, error monitoring, and inhibiting a prepotent response system (Folstein & Van
Petten, 2008). While studies have found decreased N200 amplitude for conflict adaptation (i.e.,
the adjustment of performance based on previous-trial conflict) in individuals diagnosed with
generalized anxiety disorder (GAD) and increased N200 amplitude in individuals with anxiety
sensitivity (i.e., a self-monitoring trait of anxiety), these studies were not characterized by the
subtypes of anxious arousal or anxious apprehension (Larson et al., 2013; Sehlmeyer et al.,
2010). Previous studies have not characterized the association among anxious arousal or anxious
apprehension and the N200 component during an inhibitory control task.
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N450
The N450 is one of the most commonly identified ERP components associated with the
CWST. Distinguishable as a negative-going deflection 300 – 500 ms following stimulus onset
with frontocentral topography, the N450 ERP waveform typically peaks around 450ms following
the presentation of an incongruent stimulus (Liotti et al., 2000; van Veen & Carter, 2005; West
& Alain, 1999). N450 results are relatively robust, with multiple studies reporting that
incongruent conditions elicit increased amplitude relative to congruent or neutral conditions
(Hanslmayr et al., 2008; West et al., 2005). EEG source localization efforts have consistently
reported that ACC dipoles account for the most variance in the topography of the N450
(Hanslmayr et al., 2008; Liotti, Woldorff, et al., 2000; Szűcs et al., 2009). Further, evidence
accrued from functional magnetic resonance imaging studies (fMRI) have implicated increased
ACC activity in response to incongruent compared to congruent stimuli, consistent with a role in
the detection of stimulus conflict (MacLeod & MacDonald, 2000; Szűcs & Soltész, 2012). Thus,
N450 is considered to reflect a more automatic conflict monitoring mechanism rather than
indicating intentional control functions (Suárez-Pellicioni et al., 2014). Previous studies have not
characterized the associations among anxiety subtypes and the N450 component.
Conflict SP
On response inhibition tasks, the conflict slow potential (SP) follows the N450, emerging
at central sites approximately 500 ms after stimulus onset. It is thought to be a relatively tonic,
positive sustained brain potential that is generated by the middle or inferior frontal gyrus (LPFC)
and the left extrastriatal cortices (Suárez-Pellicioni et al., 2014), and topographically appears as
sustained parietal positivity/lateral frontal negativity (Larson et al., 2009). It has been observed
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to be enhanced following correct incongruent trials compared to congruent trials or errors and
may play a role by resolving response monitoring detected by the N200 and resolving conflict
monitoring detected by the N450 (Larson et al., 2009; Suárez-Pellicioni et al., 2014). However,
the specific cognitive processes associated with the conflict SP remain under investigation. Past
studies have shown that the conflict SP is associated with response time and accuracy (West et
al., 2005). This component has not yet been characterized in individuals with anxious
apprehension or anxious arousal.
The Present Study
The present study was conducted in order to evaluate whether anxious arousal symptoms
compared to anxious apprehension symptoms differentially influence the implementation of the
temporal course of neural activity during response inhibition. The analyses were conducted in an
exploratory manner since limited research has studied the relation among anxiety symptoms and
ERPs during a “cognitive” response inhibition task. As noted above, previous research
investigating these anxiety subtypes was mostly conducted with fMRI and/or within the context
of experimental tasks involving affective stimuli. Behavioral (response time and accuracy) and
ERP components (N200, N450, and conflict SP) were analyzed in the present study.
Both categorical and dimensional approaches were used to probe the relations among
distinct dimensions of anxiety symptoms and the behavioral and neural correlates of response
inhibition. Similar to methods used in previous research to categorize individuals with
predominantly anxious arousal or anxious apprehension symptoms (Engels et al., 2007; Nitschke
et al., 1999, 2000; Sass et al., 2010; Silton et al., 2010, 2011), participants were identified as
those who scored high on anxious arousal symptoms, but low on anxious apprehension
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symptoms (Anxious Arousal Group; ARO), and vice versa (Anxious Apprehension Group;
APP). Participants in both groups scored low on affectivity measures indicative of depression
symptoms. A group of participants was also identified as those who scored low on anxious
arousal, anxious apprehensions, and depression symptoms (Control Group; CG). However, a
dimensional approach was also implemented since The National Institute of Mental Health
(NIMH) Research Domain Criteria Initiative (RDoc; Insel & Cuthbert, 2009) encourages
applying dimensional approaches to transcend traditional categorical classification (BlanchardFields, 2005; Blanchette & Richards, 2010; Mitchell & Phillips, 2007; Yiend, 2004) in order to
accurately characterize dimensions of function that are associated with the range of human
behavior. Further, we also included positive and negative affectivity dimensions to account for
variance associated with co-occurring depression symptoms.
Method
Study Overview
The present research study used archival data from a large research study that presented
color-word and emotion-word Stroop tasks during EEG and fMRI data acquisition in two
separate counter-balanced sessions. Data were collected between 2002 – 2007. Only CWST data
collected during the EEG session were investigated in the proposed study. Participants enrolled
in this study were recruited from a pool of undergraduate students who completed a series of
questionnaires as partial fulfillment of enrollment in an introductory psychology course. The
University’s Institutional Review Board approved all study methods.
Participants
Participants (N = 97) were paid volunteers recruited from introductory psychology
classes via group questionnaire screening sessions. Three participants were considered outliers
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on ERP measures (over three SDs from the mean for at least one component) and were omitted
from subsequent analyses. Casewise deletion was used to omit participants (n = 2) that had
missing responses to any questionnaires used in the present study. The final sample used for
analyses included n = 92 participants (55% female, 85% Caucasian) between the ages of 18 - 21
(M = 18.86, SD = .91). All participants were right-handed, native speakers of English with selfreported normal color vision.
Demographics
Participants reported information regarding age, gender, handedness, and ethnicity via
Scantron multiple-choice answer sheets.
Questionnaire Measures and Clinical Interview Informed Participant Selection
Participants for the present study were selected from a larger sample and categorized into
three groups (ARO, APP, CG) based on threshold cutoffs on measures of depression and anxiety
(Engels et al., 2007; Nitschke et al., 1999) for the Anhedonic Depression and Anxious Arousal
scales of the Mood and Anxiety Symptom Questionnaire (MASQ; Watson et al., 1995) and the
Penn State Worry Questionnaire (PSWQ; Meyer et al., 1990).
Cutoff scores for group membership (ARO, n = 29; APP, n = 25; CG, n = 38) were
assigned using 50th and 80th percentiles based on sample distributions for each measure. All
ARO and CG participants scored below the 50th percentile on the PSWQ. ARO participants
scored above the 80th percentile on the 17-item subscale of the MASQ-AA and below the 50th
percentile on the PSWQ and MASQ 8-item anhedonic depression (MASQ-AD-8; Nitschke et al.,
2000). APP participants scored above the 80th percentile on the PSWQ and below the 50th
percentile on the MASQ-AA and MASQ-AD-8. CG participants scored below the 50th
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percentile on the PSWQ and the MASQ-AA and anhedonic subscales. The Structured Clinical
Interview for Axis I Disorders, Non-patient edition (SCID; First et al., 1997) was also
administered to assess psychopathology. In the present study, CG participants were also required
to be free of clinical diagnoses per the SCID. All participants completed these questionnaire
measures again during their first lab visit and those are the scores that are reported in this present
study. McDonald’s Omega was obtained for each subscale of the MASQ with the original
validation sample showing moderate to high internal consistency across all three subscales
(Watson et al., 1995). The present study replicated these findings (NA, ω = .81; PA, ω = .93; and
AA, ω = .89). The present study found good internal consistency for the PSWQ (ω = .94), which
consistent with previous research (Henning et al., 2007).
Task Design
Participants completed a color-word and emotion-word Stroop tasks during an fMRI
session and an EEG session. Behavioral and EEG data from the CWST were included in the
present study. The order of presentation of the two Stroop tasks within a session was
counterbalanced across participants, as was the order of the EEG and fMRI sessions. The CWST
consisted of blocks of color-congruent or color-incongruent words alternating with blocks of
neutral words, with 256 trials in 16 blocks (4 color-congruent, 4 color-incongruent, 8 neutral).
Half of the trials in congruent and incongruent blocks were neutral to prevent the development of
word-reading strategies. There were eight orders of stimulus presentation for each Stroop task,
designed specifically to control stimulus order effects. Each participant received one of the eight
orders.
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Each trial consisted of one word presented in one of four ink colors (red, yellow, green,
blue). Trials began with the presentation of a word for 1500 ms, followed by a fixation cross for
275 ms to 725 ms (onset to onset ITI 2000 +/− 225 ms). Word presentation and response
recording were controlled by STIM software (James Long Company, Caroga Lake, NY). Words
were presented on a CRT monitor 1.35 m from the participants’ eyes, for a vertical span of 1.5
degrees and a horizontal span of 3.2 – 8.7 degrees. Participants responded with their middle and
index fingers, with each task using the same mapping of color to button. There was a color-tokey-mapping acquisition phase of 32 practice trials. In addition to the 16 word-blocks, there were
four fixation blocks – one at the beginning, one at the end, and two in the middle of the session.
In the fixation condition, a brightened fixation cross was presented for 1500 ms.
Stroop Interference
Stroop interference occurs when conflicting stimuli are simultaneously presented. In the
case of the CWST, conflicting stimuli are presented such that the name of one color (e.g., the
word “RED”) is printed in the ink of another color (e.g., blue). These task trials are referred to as
incongruent trials. Interference does not occur when stimuli characteristics agree (e.g., the word
“RED” is printed in red ink). Trials in which the word name and ink color match are referred to
as congruent trials. To obtain an index of reaction time (RT) interference, RT on correct
congruent trials was subtracted from RT on correct incongruent trials. To obtain an index of
accuracy interference, accuracy for incongruent trials was subtracted from accuracy for
congruent trials.
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Apparatus and Physiological Recording
EEG was recorded with a custom-designed Falk Minow 64-channel cap with Ag/AgCl
electrodes spaced equidistantly, extending inferiorly to the F9/F10 ring of the 10-10 System. The
left mastoid served as the online reference for all EEG and EOG sites. Electrodes were placed
above and below each eye and near the outer canthus of each eye recorded vertical and
horizontal EOG for off-line eye-movement artifact correction of EEG. Electrode impedances
were maintained below 20 kOhms. Half-power amplifier bandpass was 0.1 to 100 Hz, and data
were digitized at 250 Hz. Electrode positions were recorded using a Zebris ELPOS digitizer
(Zebris Medizintechnik, Tübingen, Germany).
EEG Data Reduction
EEG data processing was performed in Brain Electrical Source Analysis software
(BESA, Version 7.0). Following the adaptive artifact correction method (Ille, Berg, Scherg,
2002) ocular artifacts were corrected using a spatial PCA filter. Muscle and other artifacts were
removed through automated artifact scan of raw data (fixed threshold criterion: amplitude >
120uV; gradient > 75 uV, low signal <.01hz). Baseline adjustment was computed using the
averaged amplitude of 200 ms pre-stimulus onset. Data were re-referenced using an average
reference for analyses and digitally filtered with a 0.1 Hz high-pass filter and 30 Hz low-pass
filter. Stimulus-locked averages were calculated to ascertain mean amplitudes for N200, N450,
and the conflict SP. Centroid latency (Clayson et al., 2013; Dien, 2010) was computed for N200
and N450 components across conditions. Electrode selection and temporal windows were
informed by visual inspection of data as well as a priori judgments based on findings from
previous studies investigating these ERP components in similar contexts (i.e., Silton et al., 2010).
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Amplitudes were extracted within the following latency windows: N200: 220-320ms, N450: 36472ms, conflict SP: 600-900ms. EEG electrode sites for each component were based on visual
inspection of grand average waveforms and scalp topography (see Figure 2).
Figure 2. Scalp Topographies. Scalp topographies illustrating areas of maximal voltage for
N200, N450, and conflict SP after stimulus onset. For N200, values range from red = +6.38
uV/cm2 to blue = -6.38 uV/cm2. For N450, values range from red = +9.02 uV/cm2 to blue = -9.02
uV/cm2. For conflict SP, values range from red = +3.19 uV/cm2 to blue = -3.19 uV/cm2. BESA
time-domain filter used for all graphs: 0.1 - 30 Hz.
A.

N200, 276 ms

B. N450, 428 ms

C. conflict SP, 660 ms

Cz
Cz

Cz

Data Analysis Plan
All analyses were conducted with SPSS version 26.0. Descriptive statistics were
calculated for all variables (self-report measures, behavioral measures, and ERP components). A
series of repeated measures analysis of variance (ANOVAs) was conducted to examine whether
ERP components vary by congruency (i.e., congruent and incongruent trials) and to evaluate
whether group differences were observed for the ERP components. Associations among
psychological symptoms (i.e., anxious arousal, anxious apprehension, and affectivity),
behavioral measures (i.e., RT and accuracy), and ERP components (i.e., N200, N450, and
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conflict SP amplitude, N200 and N450 centroid latency) were examined using Pearson twotailed correlations. Finally, a series of linear regressions was conducted to evaluate the influence
of dimensional psychological symptoms on behavioral measures and ERP components.
Power Analysis
For the categorical approach, a sensitivity power analysis with a two-tailed significance
level of p < .05 (Aiken et al., 1991; Cohen & Servan-Schreiber, 1992) was used to determine an
appropriate effect size given our study’s sample size (Cohen, 1988). The sensitivity power
analysis was conducted in G*Power 3.1.9.2.(Faul et al., 2007) to evaluate a between-subjects
ANOVA with three levels of group. With a sample size of 92 participants and an alpha of .05,
results showed that a minimum effect size of R2 = .16 is needed to achieve power of 80%. For the
dimensional approach, a sensitivity power analysis with a two-tailed significance level of p < .05
was conducted to evaluate a linear regression analysis with four predictors (i.e., Anxious
Arousal, Anxious Apprehension, Negative Affectivity, and Positive Affectivity) and one
covariate (gender). With a sample size of 92 participants and an alpha of .05, results showed that
a minimum effect size of R2 = .15 is needed to achieve power of 80%.
Results
Group Demographics and Characteristics
Demographic characteristics of the full study sample and each diagnostic group (CG,
ARO, APP) are presented in Table 9. The groups were similar in age (F(2, 89) = .71, p = .50),
although they differed in gender composition (χ2(2, n = 92) = 9.00, p = .01), with a higher
percentage of women in the anxious apprehension group compared to the other two groups.
Participants completed SCID interviews and diagnostic counts for lifetime history of anxiety,
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depression, or co-occurring anxiety/depressive disorders are reported in Table 10. A series of
one-way ANOVAs was calculated to confirm that groups (ARO, APP, CG) differed on
dimensional psychopathology measures (affectivity, anxious arousal, and anxious apprehension;
Table 10). Bonferroni adjusted post-hoc t-tests revealed a significant difference between groups
on the anxious arousal scale (F(2,89 = 22.87, p = <.001) such that ARO participants reported
significantly higher levels of anxious arousal compared to APP (p = <.001) and CG (p = <.001).
APP and CG participants did not differ on anxious arousal scores. There was also a significant
difference between groups on the anxious apprehension scale (F(2, 89) = 72.10, p = <.001) such
that APP participants reported more anxious apprehension than CG participants (p =<.001) and
ARO participants (p = <.001). There was also a significant difference between groups on
negative affectivity (F (2, 89) = 9.21, p = <.001) such that APP participants reported
significantly more negative affectivity than CG participants (p = <.001), although no group
differences were found between APP and ARO. There were no group differences in scores for
positive affectivity.
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Table 9. Demographic Information by Full Sample and by Group (N = 92).

Full
Sample
SD

Control
(n = 38)
M

Variable

M

Age (years)
Variable
Female
Race
Caucasian
Asian
African
American
Multiracial
No Response
Note: *p <.05

18.86 .91 18.89 1.01 18.97 .91
N
% N
%
N
%
51
55.4 16 42.1 15
51.7

18.68 .75
N
%
20 80.0

78
7
3

84.8 35
7.6 2
3.3 1

92.1 24
5.3 2
2.6 2

82.8
6.9
6.9

19
3
1

76.0
12.0
4.0

3
1

3.3
1.1

0
0

3.4
0

1
1

4.0
4.0

0
0

SD

Diagnostic Group
Anxious
Anxious
Arousal
Apprehension
(n = 29)
(n = 25)
M
SD
M
SD

1
0

F (2,
89)
.71
Χ2
9.00

p
.50
p
.01*
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Table 10. Group Characteristics of Psychological Symptoms, Behavioral Measures of Response
Inhibition, and ERP Components.

Control Group
(n = 38)
SCID Diagnostic Group
Depression
Anxiety
Comorbid Anx/Dep
Dimensional Measures of
Psychopathology
MASQ-AA
MASQ-NA
MASQ-PA
PSWQ - AP
Congruent Trials
Accuracy (errors)
Response Time (ms)
N200 Amplitude (uV)
N200 Latency (ms)
N450 Amplitude (uV)
N450 Latency (ms)
SP Amplitude (uV)
Incongruent Trials
Accuracy (errors)
Response Time (ms)
N200 Amplitude (uV)
N200 Latency (ms)
N450 Amplitude (uV)
N450 Latency (ms)
SP Amplitude (uV)
Stroop Interference
Accuracy (errors)
(Con Acc-Inc Acc)
Reaction Time (ms)
(Inc RT – Con RT)

Diagnostic Group
Anxious Arousal Anxious
(n = 29)
Apprehension
(n = 25)
N
%
N
%
0
0
1
4.0
2
6.9
5
20.0
0
0
1
4.0
M
SD
M
SD

N
0
0
0
M

%
0
0
0
SD

21.24
12.39
32.79
35.42

3.48
2.28
8.77
10.70

31.07
14.17
31.34
38.24

8.03
2.87
10.75
11.73

24.52
15.88
35.56
65.32

.71
622.14
.52
407.95
4.88
413.20
1.29

1.35
76.42
2.55
7.78
2.30
4.48
2.06

1.03
630.49
.87
408.75
4.76
413.48
1.08

1.32
109.32
2.37
7.06
2.65
5.08
1.82

2.18
807.09
-.28
411.02
4.11
413.56
2.04

2.26
142.35
2.70
8.45
1.82
5.06
1.60

3.10
799.45
.74
411.91
3.89
414.25
1.78

2.32

2.78

2.31

p

6.05
4.46
8.65
7.16

F
(2,89)
22.86
9.21
1.38
72.10

.60
610.59
1.76
409.89
5.09
414.64
1.44

.82
94.77
1.62
9.78
2.01
5.22
1.66

.31
.96
2.28
.42
.13
.69
.25

.73
.39
.11
.66
.88
.50
.78

3.31
126.39
2.31
10.01
1.92
4.87
1.94

2.16
793.74
1.23
416.16
4.44
416.23
2.45

2.06
132.98
1.54
11.36
2.25
5.53
2.14

.08
1.28
3.53
2.21
.53
2.09
.85

.93
.28
.03+
.12
.59
.13
.43

3.34

1.96

2.44

.14

.87

105.54

.20

.82

184.95 113.26 168.96 100.21 183.15

<.001*^
<.001+
.26
<.001*+

Note. AA = anxious arousal, NA = negative affect, PA = positive affect, AP = anxious
apprehension/worry, RT – response time
*ARO is significantly different from APP; ^ARO is significantly different than CG; +APP is
significant different from CG
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Behavioral Results: Confirmation of Stroop Interference Effect and Evaluation of Group
Effects
Initial repeated measures ANOVAs were conducted to ensure that a Stroop interference
effect was observed for the present sample (Table 11). Indeed, incongruent RT was greater than
congruent RT (p < .001) and participants were less accurate on incongruent than congruent trials
(p <.001). Pearson correlation analyses revealed RT and accuracy for congruent and incongruent
trials were associated with each other (rs range from .23 – .61; Table 12), and slower RT was
generally related to increased accuracy indicating a RT-accuracy tradeoff. One-way ANOVAs
were conducted to evaluate the effects of categorical group on RT and accuracy for incongruent
and congruent trials. Group differences were not observed for RT, accuracy, or Stroop
interference effects (Table 11).
Table 11. Repeated Measures ANOVAs for Task Condition (Congruency) for Behavioral Data
and ERPs.
A. Accuracy (errors)
F

p

partial η2

Congruency

39.13

< .001*

.31

Congruency x Group

.48

.62

.01

F

p

partial η2

Congruency

248.90*

< .001*

.74

Congruency x Group

0.20

.82

.01

B. Response Time (ms)

C. N200 Amplitude
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F

p

partial η2

Congruency

6.71*

.01*

.07

Congruency x Group

1.18

.31

.00

F

p

partial η2

Congruency

19.67*

< .001*

.18

Congruency x Group

1.16

.32

.03

F

p

partial η2

Congruency

18.33

< .001*

.17

Congruency x Group

.12

.89

.00

F

p

partial η2

Congruency

2.78

.10

.03

Congruency x Group

.43

.65

.01

F

p

partial η2

Congruency

29.32

< .001*

.25

Congruency x Group

.35

.71

.01

D. N200 Latency

E. N450 Amplitude

F. N450 Latency

G. Conflict SP Amplitude

Note: *p <.05
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Table 12. Pearson Correlations (Bonferroni adjusted) for Full Sample.
1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

1. MASQ-AA
2. MASQ-NA

.30*

3. MASQ-PA

.03

.32*

4. PSQW

.06

.35*

.27*

5. Congruent - RT

-.03

-.04

-.03

-.03

6. Congruent - ACC

.09

.08

-.02

-.06

.27*

7. Incongruent - RT

-.07

-.13

-.06

-.07

.61*

.05

8. Incongruent - ACC

.04

.02

-.05

-.06

.23*

.27*

.40*

9. Interference – RT

-.07

-.14

-.05

-.06

-.10

-.17

.73*

.30*

10. Interference – Acc

-.02

-.05

-.11

-.01

.13

-.09

.31*

.81*

.28*

11. N200 Congruent
Amplitude

.11

.16

.06

.21*

-.25*

-.20 -.19

-.15

-.02

-.11

12. N200 Congruent Latency

.03

-.09 .06

.22*

.01

.04

-.07

-.14

-.10

-.16

13. N200 Incongruent
Amplitude

.19

.14

.06

.22*

.03

-.02

-.07

-.06

.06

-.01

14. N200 Incongruent
Latency

.02

.06

.12

-.31*

-.03

-.00

-.04

-.06

-.03

-.07

15. N450 Congruent
Amplitude

-.14

-.03

.06

.05

-.31*

-.08

-.28*

-.03

-.08

.07

16. N450 Congruent Latency

-.05

-.14

.10

.15

-.09

.04

-.13

-.19

-.09

-.25*

17. N450 Incongruent
Amplitude

-.17

.07

.05

.10

-.05

-.06

-.13

.03

-.12

.05

18. N450 Incongruent
Latency

-.13

-.07

.13

.20

-.02

.02

-.03

.14

.05

.08

19. SP Congruent Amplitude

-.22*

-.12

-.02

.07

.10

-.01

.00

.03

-.09

.11

20. SP Incongruent
Amplitude

-.33*

-.04

.04

.06

.03

-.09

-.00

.09

-.03

.05

Note: *p <.05
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ERP Components
Congruency
In order to evaluate whether the ERP components distinguish between task condition
(incongruent/congruent), and to explore potential interactions with group, a series of repeated
measure ANOVAs were conducted. Figure 3 presents the grand-average waveforms. A main
effect was observed for congruency with increased N200, N450, and conflict SP amplitude
observed on incongruent trials compared to congruent trials. A main effect was also found for
congruency with shorter N200 latency onset for congruent trials compared to incongruent trials.
A main effect was not observed for N450 latency. No significant group by congruency
interactions effects were observed.
Figure 3. Grand-Average Waveforms for Each Group. Waveforms are highlighting A) N200, B)
N450, and C) conflict SP components. Time course is depicted on the x-axis beginning 200ms
before stimulus presentation. Stimulus onset = 0ms.
A.

Control
Anxious Apprehension
Anxious Arousal
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B.

Control
Anxious Apprehension
Anxious Arousal

C.

Control
Anxious Apprehension
Anxious Arousal
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Evaluation of Categorical Group Differences on the Temporal Course of Response
Inhibition
In order to characterize group differences on ERP components, repeated measures
ANOVAs were conducted for each ERP component (N200 incongruent/congruent amplitude and
centroid latency, N450 incongruent/congruent amplitude and centroid latency, conflict SP
incongruent/congruent amplitude). Bonferroni adjusted post-hoc t-tests revealed a greater N200
amplitude on incongruent trials for APP participants compared to CG participants (p < .001).
There were no other significant group differences for ERP components. Table 11 provides
statistical results of the group comparisons for ERP components.
Correlations among psychological symptoms, behavioral measures, and ERPs
Prior to conducting dimensional regression analyses, Pearson correlations were computed
among the primary study variables to evaluate the relations between psychological symptoms,
behavioral measures, and ERP components (Table 12). Key relations are highlighted in the
following sections.
Psychological symptoms
Psychological symptoms were generally related to each other (rs range .27 – .35),
although anxious arousal was not related to positive affectivity or anxious apprehension. Higher
levels of anxious arousal were related to attenuated conflict SP amplitude for both congruent and
incongruent trials (rs = -.22 and -.33, respectively). Higher levels of worry were associated with
larger N200 amplitudes for congruent and incongruent trials (rs = .21 and .22, respectively).
Further, increased anxious apprehension was associated with N200 latency onset for congruent
trials (r = .22), with later latency associated with increased anxious apprehension. A relation in
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the opposite direction was observed with regard to latency for incongruent trials such that
increased anxious apprehension was related to earlier latency (r = -.31).
RT, accuracy, and ERP components
RT and accuracy for congruent and incongruent trials were associated with each other
(rsrange from .23 – .61), and slower RT was generally related to increased accuracy. Increased
accuracy for congruent trials was associated with increased accuracy for incongruent trials (r =
.27). Congruent trial RT was associated with N200 and N450 amplitude for congruent trials (rs =
-.25, -.31), such that slower RT was associated with reduced N200 and N450 amplitudes for
congruent trials. Lastly, Stroop interference accuracy was associated with slower N450 latency.
Evaluation of the influence of dimensional psychopathology symptoms on the temporal
course of response inhibition
A series of linear regressions was conducted to evaluate the dimensional effect of
psychopathological symptoms on response inhibition. Outcome variables were behavioral
measures and ERP components. Psychopathology symptoms (anxious arousal, anxious
apprehension, affectivity) were simultaneously entered as predictors. Significant findings are
reviewed below and regression results for all models can be found in Tables 13 - 15.
N200
There were no significant findings observed for N200 amplitude for congruent or
incongruent trials. With regard to congruent latency, higher levels of anxious apprehension were
related to later N200 latency (B = .14, p = .01). The regression model was not significant
(F(4,87) = 2.12, p = .09). For incongruent trials, higher levels of anxious apprehension were
related to later N200 latency (B = .20, p < .001) and higher negative affectivity was related to
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earlier N200 latency (B = -.72, p = .03). The regression model was significant (F(4, 87) = 3.62, p
= .01).
N450
There were no significant findings for N450 amplitude for congruent or incongruent
trials. With regard to N450 congruent latency, higher negative affectivity was related to earlier
N450 latency (B = .07, p = .03). The regression model was not significant (F(4, 87) = 1.84, p =
.13). With regard to N450 incongruent latency, higher levels of anxious apprehension were
related to later N450 latency (B = .07, p = .04). The regression model was not significant (F(4,
87) = 2.01, p = .09).
Conflict SP Amplitude
Psychological symptoms did not predict congruent conflict SP amplitude. For
incongruent trials, results showed that higher levels of anxious arousal symptoms were related to
more negative conflict SP amplitude (B = -.09, p = .00). The regression model was significant
(F(4, 87) = 2.91, p = .03).
Table 13. Dimensional Regression Summary Statistics for Stroop Interference.
A. Stroop Interference Reaction Time

B

SE

t (p)

95% CI

R2
R2 = .02,
F (4, 87) = .44
p = .78

Variable

MASQ-AA

-.47

1.65

-.29 (.78)

[-3.74, 2.81]

MASQ-NA

-3.75

3.80

-.99 (.33)

[-11.30, 3.80]

MASQ-PA

-.08

1.29

.06 (.95)

[-2.63, 2.49]

82
PSWQ

-.72

0.75

-.10 (.92)

[-1.56, 1.41]

B. Stroop Interference Accuracy

B

SE

t (p)

95% CI

R2
R2 = .01,
F (4, 87) = .28
p = .89

Variable

MASQ-AA

-.01

.04

-.12 (0.91)

[-.09, .08]

MASQ-NA

-.01

.10

-.01 (0.92)

[-.21, .19]

MASQ-PA

-.03

.04

-.10 (0.34)

[-.10, .04]

PSWQ

.00

.02

.19 (0.85)

[-.04, .04]

Table 14. Dimensional Regression Summary Statistics for Congruent Trials.
A. Reaction Time for Congruent Trials

B

SE

t (p)

95% CI

R2
R2 = .02,
F (4, 87) = .05
p = .996

Variable

MASQ-AA

-.24

1.44 -.17 (.87)

[-3.31, 2.48]

MASQ-NA

-.43

3.32 -.13 (.90)

[-6.78, 6.51]

MASQ-PA

-.16

1.12 -.15 (.89)

[-2.36, 2.12]

PSW

-.12

.65

[-1.75, 1.05]

-.18 (.86)

B. Accuracy for Congruent Trials
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B

SE

t (p)

95% CI

R2
R2 = .02,
F (4, 87) = .41
p = .80

Variable

MASQ-AA

.01

.02

.59 (.56)

[-.03, .05]

MASQ-NA

.03

.04

.79 (.43)

[-.05, .12]

MASQ-PA

-.00

.02

-.22 (.83)

[-.03, .03]

PSWQ

-.01

.01

-.76 (.45)

[-.02, .01]

C. N200 Amplitude for Congruent Trials

B

SE

t (p)

95% CI

R2
R2 = .06,
F (4, 87) = 1.29
p = .28

Variable

MASQ-AA

.02

.04

.66 (.51)

[-.05, .09]

MASQ-NA

.05

.08

.63 (.53)

[-.10, .22]

MASQ-PA

-.01

.03

-.16 (.87)

[-.06, .05]

PSWQ

0.03

0.02 1.60 (.11)

[-.01, .06]

D. N200 Latency for Congruent Trials
B

SE

t (p)

95% CI

R2
R2 = .09,
F (4, 87) = 2.12
p = .09

Variable

MASQ-AA

.10

.12

.79 (.46)

[-.15, .34]

MASQ-NA

-.55

.28

-1.97 (.06)

[-1.11, .01]

MASQ-PA

.05

.10

.49 (.62)

[-.14, .23]

PSWQ

.14

.06

2.25 (.01)*

[.03, .25]
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E. N450 Amplitude for Congruent Trials
B

SE

t (p)

95% CI

R2
R2 = .03,
F (4, 87) =.58
p = .68

Variable

MASQ-AA

-.04

.04

-1.21 (.23)

[-.12, .03]

MASQ-NA

-.02

.08

-.23 (.82)

[-.18, .15]

MASQ-PA

.02

.03

.54 (.59)

[-.04, .07]

PSWQ-AP

.01

.02

.50 (.65)

[-.03, .04]

F. N450 Latency for Congruent Trials
B

SE

t (p)

95% CI

R2
R2 = .08,
F (4, 87) = 1.84
p = .13

Variable

MASQ-AA

.01

.07

.13 (.90)

[-.14, .16]

MASQ-NA

-.36

.17

-2.1 (.04)*

[-.70, -.02]

MASQ-PA

.07

.06

1.16 (.25)

[-.05, .18]

PSWQ

.06

.03

1.85 (.07)

[-.005, .13]

G. SP Amplitude for Congruent Trials
B

SE

t (p)

95% CI

R2
R2 = .06,
F (4, 87) = 1.40
p = .24

Variable

MASQ-AA

-.05

.03

-1.77 (.08)

[-.11, .01]

MASQ-NA

-.05

.07

-.78 (.44)

[-.18, .08]

MASQ-PA

-.002

.02

-.08 (.94)

[-.05, .04]

PSWQ

.01

.01

.995 (.32)

[-.01, .04]
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Table 15. Dimensional Regression for Incongruent Trials.
A. Reaction Time for Incongruent Trials

B

SE

t (p)

95% CI

R2
R2 = .02,
F (4, 87) = .44
p = .78

Variable

MASQ-AA

-.71

2.07

-.34 (.73)

[-4.83, 3.41]

MASQ-NA

-4.19

4.78

-.88 (.38)

[-13.68,
5.30]

MASQ-PA

-.24

1.61

-.15 (.88)

[-3.45, 2.97]

PSWQ

-.19

.94

-.20 (.84)

[-2.06, 1.68]

B. Accuracy for Incongruent Trials

B

SE

t (p)

95% CI

R2
R2 = .01,
F (4, 87) = .17
p = .95

Variable

MASQ-AA

.01

.04

.23 (0.81)

[-.07, .09]

MASQ-NA

.03

.09

.36 (0.64)

[-.15, .22]

MASQ-PA

-.01

.03

-.39 (0.73)

[-.08, .05]

PSWQ

-.01

.02

-.58 (0.37)

[-.05, .03]

C. N200 Amplitude for Incongruent Trials

B
Variable

SE

t (p)

95% CI

R2
R2 = .08,
F (4, 87) = 1.88
p = .12
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MASQ-AA

.06

.04

1.56 (.12)

[-.02, .13]

MASQ-NA

.01

.08

.15 (.88)

[-.15, .18]

MASQ-PA

-.003

.03

-.10 (.92)

[-.06, .05]

PSWQ

.03

.02

1.86 (.07)

[-.002, .06]

D. N200 Latency for Incongruent Trials
B

SE

t (p)

95% CI

R2
R2 = .14,
F (4, 87) = 3.62
p = .01*

Variable

MASQ-AA

.10

.14

.70 (.49)

[-.19, .39]

MASQ-NA

-.72

.33

-2.20 (.03)*

[-1.38, -.06]

MASQ-PA

.11

.11

.99 (.33)

[-.11, .33]

PSWQ

.20

.07

3.37 (< .001)*

[.09, .35]

E. N450 Amplitude for Incongruent Trials
B

SE

t (p)

95% CI

R2
R2 = .05,
F (4, 87) = 1.12
p = .35

Variable

MASQ-AA

-.06

.03

-1.87 (.07)

[-.12, .004]

MASQ-NA

.06

.07

.91 (.37)

[-.07, .20]

MASQ-PA

.00

.02

-.01 (.99)

[-.05, .05]

PSWQ

.01

.02

.60 (.55)

[-.02, .04]

F. N450 Latency for Incongruent Trials
B
Variable

SE

t (p)

95% CI

R2
R2 = .09,
F (4, 87) = 2.09
p = .09

87
MASQ-AA

-.07

.08

-.93 (.36)

[-.26, .08]

MASQ-NA

-.24

.18

-1.36 (.18)

[-.60, .11]

MASQ-PA

.07

.06

1.08 (.28)

[-.06, .19]

PSWQ

.07

.04

2.11 (.04)*

[.04, .15]

G. SP Amplitude for Incongruent Trials
B

SE

t (p)

95% CI

R2
R2 = .12,
F (4, 87) = 2.91
p = .03*

Variable

MASQ-AA

-.09

.03

-3.28 (<.001)*

[-.15, -.04]

MASQ-NA

.02

.06

.34 (.72)

[-.10, .15]

MASQ-PA

.004

.02

.17 (.86)

[-.04, .05]

PSWQ-AP

.01

.01

.53 (.68)

[-.02, .03]

Note: *p <.05
Discussion
The present study was conducted in order to determine whether dimensions of anxiety
symptoms (i.e., anxious arousal and anxious apprehension) distinctly modulated the temporal
course of neural activity related to response inhibition during a cognitive Color-Word Stroop
Task (CWST). ERP results indicated that dimensional psychopathology symptoms uniquely
impact the cascade of cognitive resources implemented during response inhibition. Relative to
categorical group analyses, results from dimensional analyses with psychopathology symptoms
(anxious arousal, anxious apprehension, and affectivity) offered a more nuanced view regarding
how different dimensions of anxiety symptoms impact the temporal course of response
inhibition, such that anxious apprehension modulated N200 and N450, and anxious arousal
influenced the conflict SP. Anxious apprehension was found to impact response inhibition earlier
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in the processing stream, which may represent attentional interference and difficulties efficiently
monitoring stimuli, while anxious arousal impacted response inhibition later in the processing
stream, which may indicate a failure to efficiently sustain effective top-down control due to
difficulty regulating sustained inhibitory control.
Categorical group analyses showed that the anxious apprehension group elicited a greater
N200 amplitude on incongruent trials compared to the control group, suggesting difficulties with
conflict monitoring for those with anxious apprehension. Related to this finding, dimensional
analyses showed that higher levels of anxious apprehension were related to later N200 latency
for congruent and incongruent trials. Higher negative affectivity (anhedonic depression
symptoms) was also related to earlier N200 latency for incongruent trials, indicating opposing
effects of anxious apprehension and negative affectivity on early conflict monitoring processes.
In sum, during early conflict monitoring processes as indexed by N200, high levels of anxious
apprehension were associated with increased amplitude and later latency for incongruent trials
which indicates that increased neural resources (likely reflective of ACC generators) were
recruited and corresponded with a later engagement with conflict monitoring processes. Of note,
although we used a “cognitive” color-word Stroop task in the present study, resolving cognitive
conflict may generate state negative affect (Inzlicht et al., 2015), which could instantiate worry
and ruminative processes in individuals with anxious apprehension, resulting in attentional
interference and difficulties efficiently monitoring stimuli.
Similar to the pattern of results that emerged for N200, only anxious apprehension
impacted incongruent N450 latency (and negative affectivity was related to congruent N450
latency). N450 has been associated with conflict resolution and it is theorized to also reflect ACC
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activity (Liotti, Woldorff, et al., 2000; MacLeod & MacDonald, 2000; Szűcs & Soltész, 2012).
Thus, anxious apprehension was related to later engagement with conflict resolution processes,
likely indicating difficulties with quickly selecting responses for incongruent stimuli, which may
be related to ruminative tendencies that slow down decision-making processes.
Anxious arousal distinctly attenuated the later conflict SP amplitude for incongruent
trials. Conflict SP has been theorized to reflect later response inhibition processes such as
response selection and conflict adaptation/resolution processes, indicative of middle or inferior
frontal gyrus and left extrastriatal cortical function and is suggestive of a more sustained, topdown control mechanism (Chen et al., 2011; Larson et al., 2011, 2014; Smith, 2017). Reduced
conflict SP amplitude for incongruent trials in individuals reporting higher levels of anxious
arousal may indicate a failure to sustain efficient top-down inhibitory control processing and
poor signaling of conflict resolution (Smith, 2017).
As expected from previous findings (e.g., Harnishfeger, 1995; MacLeod, 1991; Silton et
al., 2011; West et al., 2005), the present study showed that the behavioral costs of interference
processing were observed through increased difficulty (i.e., increased RT and error rate) and
increased recruitment of neural resources (e.g., increased ERP amplitude; delayed N200 centroid
latency) for incongruent trials compared to congruent trials across the entire sample. We did not
observe a main effect of psychological symptoms on behavioral outcomes in either the
categorical or dimensional analyses. Further, it appears that effect size for behavioral outcomes
is smaller than our observed effect sizes for our ERP data, indicating that a larger sample would
be required to observe relations among psychopathology symptoms and behavioral outcomes.
Alternatively, it remains plausible that compensation is occurring in other subcortical brain
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regions that are not fully observable via ERP scalp analyses that measure cortical regions located
near the surface of the brain.
These findings not only support dissociable brain processes during the temporal course of
response inhibition, but also provide additional support for orthogonal anxiety symptoms.
Consistent with previous research identifying arousal and anxious apprehension as unique
subtypes of anxiety (Engels et al., 2007, 2010; Guha et al., 2020; Heller et al., 1997), anxious
apprehension was shown to impact early inhibitory control processes, indicating increased
recruitment of neural resources and later engagement with conflict monitoring and conflict
resolution processes. Anxious arousal was related to later inhibitory control processes involved
in response selection and monitoring of response. Further supporting the theory that anxious
arousal and anxious apprehension represent orthogonal symptom dimensions, nearly all
psychological symptoms were correlated with each other with the exception of anxious arousal,
which was not correlated with either anxious apprehension or positive affectivity.
Limitations and Future Directions
While this study has several strengths, several limitations should be noted. Though the
study sample size was confirmed to be appropriately powered for a minimum effect size of R2 =
.16, it may be underpowered to detect behavioral differences. Further, the sample was
compromised of undergraduate students largely representing a subclinical sample. It would be
useful to replicate this study in a community-based sample with a range of clinical anxiety
disorders for generalizability. Chronic pain has been shown to be distinctly associated with
anxious arousal and self-reported inhibitory control difficulties (Polnaszek et al., in prep).
Understanding the temporal course of response inhibition through experimental measures may be
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helpful in discerning the mechanisms by which anxious arousal may affect response inhibition in
chronic pain. Treatments targeting this mechanism could be efficacious in ameliorating chronic
pain symptoms associated with poor inhibitory control.
Conclusions
In this exploratory study, we evaluated whether anxious arousal symptoms compared to
anxious apprehension symptoms differentially influence the implementation of the temporal
course of neural activity during response inhibition. Anxious apprehension impacted response
inhibition earlier in the processing stream, which may represent attentional interference and
difficulties efficiently monitoring stimuli due to ruminative processes (i.e., worry). Relative to
healthy controls, individuals with anxious arousal exhibited similar patterns of neural activity
earlier in the processing stream; however, response inhibition was impacted later in the
processing stream for individuals high in anxious arousal, which may indicate a failure to
efficiently sustain effective top-down control due to difficulty regulating sustained inhibitory
control. This may be due to difficulty tuning out irrelevant stimuli and maintaining attention to
the task at hand. It is possible that those with high anxious arousal may work harder to exert
effort early on during response inhibition, but they are unable to sustain this effort throughout
each trial. Through studying both categorical and dimensional approaches to probe the relations
among distinct dimensions of anxiety symptoms and their relations with behavioral and neural
correlates of response inhibition, this study illustrated the importance of dimensional anxiety
subtypes in order to advance our understanding of the distinct mechanisms by which they
influence response inhibition. Understanding these distinct mechanisms may help inform

92
treatments that target the unique effects of anxious arousal and anxious apprehension on
inhibitory control.

CHAPTER FIVE
DISCUSSION
The present set of studies assessed the relation between neural, psychological, and
cognitive mechanisms that have been shown to influence the experience of chronic pain.
Specifically, Studies One and Two advanced our understanding of chronic pain by illustrating its
unique relationship with anxious arousal and frontal neural activity on inhibitory control
difficulties. Study Three focuses on targeting how anxious arousal is distinctly associated with
neural correlates of inhibitory control in order to provide a framework that can be applied to
individuals experiencing chronic pain. Together, these studies aim to inform the development of
evidenced-based interventions that target anxious arousal in order to enhance the effectiveness of
chronic pain management.
Study One, “Somatic Symptoms Distinctly Influence Visceral Nociceptive Mechanisms
in Primary Dysmenorrhea,” advanced our understanding regarding how psychological (somatic
symptoms, depression, anxiety) and physiological (EEG resting state activity) mechanisms relate
to increased pain perception in women with and without dysmenorrhea. Findings from this study
indicated that chronic pain (i.e., dysmenorrhea) and increased somatic symptoms were
significant predictors of increased pain perception during an experimentally induced bladder pain
task. Depression and anxiety were associated with experimental bladder pain, although neither
significantly predicted bladder pain. While PFC resting-state activity was not a significant
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predictor of experimental bladder pain, bladder pain was correlated with increased frontal
alpha power, specifically the lower-2 alpha band, and anxiety was associated with increased
frontal
beta power irrespective of group membership. Frontal alpha and beta activity have been
associated with anticipatory processes and attentional demands (particularly expectancy)
(Klimesch et al., 1998; Klimesch, 1999; Michels et al., 2008) which have a key role in pain
perception and modulation (Moont et al., 2010; Quiton & Greenspan, 2007). Abnormalities in
PFC function have also been implicated in somatic symptoms (Hakala et al., 2002) as well as
depression and anxiety disorders (Latthe et al., 2006).
Individuals who live with chronic pain report deficits in cognitive control (Shackman et
al., 2011), which could be related to frequent and perseverative rumination about pain, or
repetitively thinking about the causes and consequences of negative pain-related experiences
(Sullivan et al., 2001). The findings from this study indicated that individuals experiencing pain
and reporting high levels of somatic symptoms, or somatic arousal, were predictive of perceiving
more pain when exposed to additional pain through an experimental pain task. Further, brain
activity in the alpha and beta bands were associated with pain and anxiety, though not predictive
of increased experimental pain. Thus, understanding the mechanisms by which anxious (i.e.,
somatic) arousal and PFC activity, particularly in the involvement of cognitive (i.e., inhibitory)
control, affect pain perception sensitivity in individuals experiencing chronic pain is essential in
reducing the risk for developing increased chronic pain symptoms in the future.
Some of the factors that influence the relation between psychological symptoms, EF, and
neural correlates are illustrated by the Study Two titled, “Chronic Pain and Inhibitory Control in
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Emerging Adults: The Role of Psychological Symptoms.” Study Two utilized a cross-sectional
approach to understanding the role psychological symptoms play in the relation between chronic
pain and inhibitory control. Individuals experiencing chronic pain may be especially vulnerable
to inhibitory control deficits. The study used a sample of emerging adults, as this age range (18 27) has been identified as a critical developmental window for executive function optimization,
particularly inhibitory control. Co-occurring psychological symptoms may also exacerbate
inhibitory control dysfunction. Motivated by findings from Study One which showed that high
levels of anxious (i.e., somatic) arousal were related to higher discomfort during an experimental
bladder task in individuals with dysmenorrhea, Study Two characterized the role of anxious
arousal in an emerging adult population with chronic pain and disentangled the contributions of
depression and anxiety symptoms with regard to impairments in inhibitory control. Results
showed that chronic pain was associated with higher levels of negative affectivity, worry, and
anxious arousal, as well as lower levels of positive affectivity. However, results from our
exploratory parallel mediation analysis showed that only negative affectivity, positive affectivity,
and anxious arousal mediated the indirect relation between pain group and inhibitory control.
Notably, worry, or anxious apprehension, was not a significant mediator, indicating that with
regard to anxiety symptoms, anxious arousal may be distinctly related to cognitive outcomes for
individuals with chronic pain. Furthermore, Study Two characterized chronic pain prevalence in
a large sample of emerging adults, a population that has been relatively understudied in chronic
pain research despite risk factors associated with this age group (e.g. complex developmental and
social transitions that necessitate the need for good self-management strategies). Thus,
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psychosocial interventions that target affectivity and anxious arousal symptoms may improve
inhibitory control function in emerging adults with chronic pain.
The third study in this series, “Anxious Arousal and Anxious Apprehension are Distinctly
Related to the Temporal Course of Response Inhibition,” built upon findings from Study Two,
by identifying how distinct dimensions of anxiety symptoms are associated with neural correlates
of inhibitory control. The study utilized an experimental cognitive neuroscience measure of
response inhibition (The Color Word Stroop Task). The study used both categorical and
dimensional approaches to probe the relations among these distinct dimensions of anxiety
symptoms and the behavioral and neural correlates of response inhibition. ERP results indicated
that dimensional psychopathology symptoms distinctly impact the cascade of cognitive resources
implemented during response inhibition. Relative to categorical group analyses (e.g., anxiety
subtype groups), results from dimensional analyses with psychopathology symptoms (anxious
arousal, anxious apprehension, and affectivity) offered a more nuanced view regarding how
different symptoms impact the temporal course of response inhibition. Anxious apprehension
impacted response inhibition earlier in the processing stream, which may represent attentional
interference and difficulties efficiently monitoring stimuli. Anxious arousal impacted response
inhibition later in the processing stream, which may indicate a failure to efficiently sustain
effective top-down control due to difficulty regulating sustained inhibitory control. This may be
due to difficulty tuning out irrelevant stimuli and maintaining attention to focus on the task at
hand. Understanding these distinct mechanisms may help inform treatments that target the
unique effects of anxious arousal and anxious apprehension on inhibitory control.
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Overall, the findings from this set of studies highlighted the cross-sectional relation
between EF, psychological symptoms, and neural mechanisms and specifically distinguished the
importance of anxious arousal, inhibitory control, and neural mechanisms measured with EEG
(i.e., frontal alpha and beta) and ERP (N200, N450, Conflict SP) methodologies.
Future Directions
Considering the separate dimensions that are encompassed under the term “anxiety”,
studying the influence of anxious arousal on the neural correlates of inhibitory control helps to
clarify how these constructs are related, and the extent to which inhibitory control deficits are a
transdiagnostic cognitive symptom that may be present across anxiety types, particularly when
considering the role of anxiety in chronic pain per the fear-anxiety-avoidance model. Studies
One and Two provide evidence for the distinct relationship between anxious arousal and selfreported and observed (i.e., frontal neural mechanisms) inhibitory control in individuals
experiencing chronic pain. Study Three identifies the distinct temporal course of inhibitory
control via anxious arousal. Thus, focusing studies that further elucidate this relationship,
including a follow-up study of Study Three with individuals experiencing chronic pain, is an
imperative next step.
Another future step includes studying interventions that may specifically target anxious
arousal in individuals experiencing chronic pain. A promising line of research is emerging with
mindfulness-based interventions. Studies have shown that mindfulness may ameliorate pain
symptoms by reducing somatic (i.e., anxious) arousal (Berkovich-Ohana et al., 2012; Travis et
al., 2010). Mindfulness practices have been hypothesized to reallocate cognitive resources that
are often focused on pain perception in individuals with chronic pain. This may allow cognitive
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processes that are important for implementing activities of daily living to be utilized more readily
(Kerr et al., 2013). However, studies are still elucidating how, and for whom, mindfulness
interventions for pain management are most effective (Day et al., 2014). Understanding the
nuanced roles of dimensional anxiety symptoms may be helpful in closing the theoretical gap in
the literature that is needed to improve empirically-based treatments for chronic pain
management (Day et al., 2014). Thus, studies that focus on tailoring mindfulness therapies for
chronic pain management that specifically target anxious arousal may lead to developing more
effective treatments for individuals with chronic pain.
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